Influence of Metabolism on Epigenetics and Disease
Open accessAbstract
Chemical modifications of histones and DNA, such as histone methylation, histone acetylation, and DNA methylation, play critical roles in epigenetic gene regulation. Many of the enzymes that add or remove such chemical modifications are known, or might be suspected, to be sensitive to changes in intracellular metabolism. This knowledge provides a conceptual foundation for understanding how mutations in the metabolic enzymes SDH, FH, and IDH can result in cancer and, more broadly, for how alterations in metabolism and nutrition might contribute to disease. Here, we review literature pertinent to hypothetical connections between metabolic and epigenetic states in eukaryotic cells.
Verified 2026-10-06 · 1 reference not checked yet
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 142 cited sources checked · 0 supported · 0 flagged
- Findingcitation
Chemical inhibition of threonine dehydrogenase in undifferentiated mouse embryonic stem cells causes intracellular acetyl-CoA to fall sharply.
“When undifferentiated ESCs are exposed to a specific chemical inhibitor of the TDH enzyme, intracellular levels of acetyl-CoA drop precipitously”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Alexander et al., 2011 source
Not checked in the free run.
- Findingcitation
In yeast, many acetylation marks on histone H3 and H4 appear only during a 30-45 min window at the oxidative-to-reductive building boundary, coinciding with peak acetyl-CoA.
“numerous acetylation marks on the K9, K14, K23, and K27 residues of histone H3 and the K5, K8, and K12 residues on histone H4 only appear over a 30–45 min window corresponding exactly with the Ox/RB boundary that is coincident with the peak abundance of intracellular acetyl-CoA.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Cai et al., 2011
Not checked in the free run.
- cites Cai and Tu, 2011
Not checked in the free run.
- cites Cai and Tu, 2012 source
Not checked in the free run.
- Findingcitation
Undifferentiated mouse embryonic stem cells contain significantly more acetyl-CoA than embryoid body cells induced to differentiate by leukemia-inhibitory factor withdrawal and retinoic acid.
“Undifferentiated ESCs contain significantly higher levels of acetyl-CoA than the embryoid body (EB) cells induced to differentiate by the combined withdrawal of leukemia-inhibitory factor (LIF) and application of retinoic acid (RA)”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Wang et al., 2009a
Not checked in the free run.
- cites Wang et al., 2011 source
Not checked in the free run.
- Findingcitation
Intracellular acetyl-CoA levels fluctuate substantially in biological settings, as shown in yeast and mouse embryonic stem cells.
“Studies of two different eukaryotic cells have indeed given evidence of significant fluctuation in acetyl-CoA.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Klevecz et al., 2004 source
Not checked in the free run.
- cites Tu et al., 2005
Not checked in the free run.
- cites Tu and McKnight, 2006
Not checked in the free run.
- Findingcitation
The off-rate of acetyl-CoA binding to yeast GCN5 is more than tenfold faster than that of human p300/CBP HAT, human GCN5, or Tetrahymena GCN5.
“the off-rate of acetyl-CoA binding to the yeast GCN5 enzyme is more than an order of magnitude more rapid than that of human p300/CBP HAT enzyme, human GCN5, or Tetrahymena GCN5”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Langer et al., 2002 source
Not checked in the free run.
- Findingcitation
Acetyl-CoA levels peak at a sixfold higher level at the oxidative-to-reductive building transition than in the reductive charging phase of the yeast metabolic cycle.
“Acetyl-CoA levels peak at a 6-fold-higher level at the transition of the oxidative (Ox) phase to the reductive building (RB) phase relative to the metabolically quiescent, reductive charging (RC) phase of the YMC”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Cai et al., 2011
Not checked in the free run.
- cites Tu et al., 2007
Not checked in the free run.
- Findingcitation
The GCN5 histone acetylase of the SAGA complex is the critical enzyme responsible for transient acetylation of growth genes at the oxidative-to-reductive building boundary.
“The GCN5 histone acetylase enzyme of the SAGA complex has been identified as the critical enzyme responsible for transient acetylation of growth genes at the Ox/RB boundary”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Cai et al., 2011
Not checked in the free run.
- Findingcitation
DNA microarray and ChIP-seq experiments identified about 1,000 growth genes that are selectively acetylated and activated only when acetyl-CoA levels peak.
“Further DNA microarray and ChIP-seq experiments led to the identification of roughly 1,000 growth genes selectively acetylated and activated only when intracellular levels of acetyl-CoA peak”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Cai et al., 2011
Not checked in the free run.
- cites Tu et al., 2005
Not checked in the free run.
- Findingcitation
Catalytically active GCN5 is required for oscillation of the yeast metabolic cycle.
“catalytically active GCN5 is critically required for YMC oscillation”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Cai et al., 2011
Not checked in the free run.
- Findingcitation
When NAD+ levels were measured across the yeast metabolic cycle, no changes were observed.
“when NAD+ levels were measured as a function of the YMC, which is far more robust in amplitude than metabolic fluctuation taking place as a function of the circadian cycle, no changes in NAD+ levels were observed”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Tu et al., 2007
Not checked in the free run.
- Findingcitation
Extensive studies of yeast under various nutritional states, including caloric restriction, show no alteration in NAD+ or nicotinamide levels that could increase sirtuin activity upon glucose restriction.
“extensive studies of yeast cells exposed to a variety of nutritional states, including caloric restriction, have shown no alteration in NAD+ or nicotinamide levels that could be interpreted to increase the activity of sirtuin enzymes upon glucose restriction”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Evans et al., 2010 source
Not checked in the free run.
- Findingcitation
Mouse embryo fibroblast cells deficient in CLOCK contain only 4-5% as much NAD+ as wild-type cells.
“Mouse embryo fibroblast (MEF) cells deficient in the CLOCK transcription factor were reported to contain only 4%–5% as much NAD+ as wild-type MEF cells”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Nakahata et al., 2009 source
Not checked in the free run.
- Premisecitation
Acetyl-CoA serves as the substrate for histone acetyltransferase enzymes that modify histone tails and thereby shape the epigenetic state of chromatin.
“Acetyl-CoA is also the substrate used by histone acetyl transferase (HAT) enzymes to modify histone tails as an integral determinant of the epigenetic state of chromatin in eukaryotic cells”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Lee and Workman, 2007
Not checked in the free run.
- cites Shahbazian and Grunstein, 2007 source
Not checked in the free run.
- Premisenone given
Many enzymes that add or remove histone and DNA modifications are known or suspected to respond to changes in intracellular metabolism.
“Many of the enzymes that add or remove such chemical modifications are known, or might be suspected, to be sensitive to changes in intracellular metabolism.”
Quote in the paperNot a substantial claim- Rests on an assumption: Histone and DNA chemical modifications are central to epigenetic control of gene expression.
- Premisecitation
During the yeast metabolic cycle, cells alternate between oxidative and reductive growth over a 4-5 hr period.
“Over a 4–5 hr cycle the cells rhythmically oscillate between oxidative and reductive growth”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Tu et al., 2005
Not checked in the free run.
- cites Tu and McKnight, 2006
Not checked in the free run.
- cites Tu et al., 2007
Not checked in the free run.
- Premisecitation
Wild-type yeast in a nutrient-restricted chemostat enter a synchronized, robust metabolic cycle without external synchronization.
“prototrophic (wild-type) strains of yeast grown in the nutrient-limiting environment of a chemostat spontaneously enter a synchronous and highly robust metabolic cycle”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Klevecz et al., 2004 source
Not checked in the free run.
- cites Tu et al., 2005
Not checked in the free run.
- cites Tu and McKnight, 2006
Not checked in the free run.
- Interpretationreasoning
Changes in metabolic state and diet could play a role in disease.
“for how alterations in metabolism and nutrition might contribute to disease.”
Quote in the paperSubstantial claim- Rests on an assumption: Histone and DNA chemical modifications are central to epigenetic control of gene expression.
- Premisecitation
SIRT3 deacetylates AceCS2 and thereby reactivates its conversion of acetate into acetyl-CoA.
“SIRT3-mediated deacetylation of AceCS2 reactivates the enzyme.”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
GCN5 histone acetyltransferase of SAGA is critical for histone acetylation in response to glucose and growth factors in otherwise quiescent cells.
“the GCN5 histone acetyltransferase enzyme of the SAGA complex is of critical importance for histone acetylation in response to the combined provision of glucose and growth factors to otherwise quiescent cells.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Wellen et al., 2009 source
Not checked in the free run.
- Premisecitation
The SIRT6 target gene set overlaps substantially with genes that depend on c-Myc and SAGA/GCN5.
“the battery of SIRT6 target genes (Sebastián et al., 2012) has been reported to overlap significantly with genes codependent on the c-Myc oncoprotein and the SAGA/GCN5 histone acetylase complex”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Sebastián et al., 2012 source
Not checked in the free run.
- cites Cai et al., 2011
Not checked in the free run.
- cites Ji et al., 2011
Not checked in the free run.
- Interpretationreasoning
Yeast and human cancer cells may use similar strategies to couple nutrient availability to gene expression.
“both yeast and human cancer cells may employ similar strategies to couple nutrient availability to the control of gene expression.”
Quote in the paperSubstantial claim- Rests on an assumption: Histone and DNA chemical modifications are central to epigenetic control of gene expression.
- Premisecitation
β-hydroxybutyrate is produced at millimolar quantities after prolonged exercise or starvation.
“β-hydroxybutyrate, which is one of the three ketone bodies, is produced at mM quantities after prolonged exercise or starvation”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Candido et al., 1978 source
Not checked in the free run.
- Premisecitation
NAD+/NADH levels do not change with starvation, whether bound or free fractions are measured.
“NAD+/NADH levels do not change as a function of starvation, irrespective of whether one measures bound or free fractions of the cofactors”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Krebs and Veech, 1969
Not checked in the free run.
- cites Veech et al., 1969 source
Not checked in the free run.
- Premisereasoning
The methyl group of SAM is chemically activated by the positive charge on the adjacent sulfur atom, making it more reactive than the methyl group on N5-MTHF.
“The methyl group of SAM is chemically activated via the positive charge on the adjacent sulfur atom, which causes the SAM methyl group to be considerably more reactive than the methyl group on N5-MTHF.”
Quote in the paperNot a substantial claim - Premisecitation
β-hydroxybutyrate inhibits many NAD+-independent histone deacetylase enzymes, like sodium butyrate.
“Like sodium butyrate, β-hydroxybutyrate inhibits the activities of many NAD+-independent histone deacetylase enzymes”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Shimazu et al., 2013 source
Not checked in the free run.
- Interpretationcitation
Cancer cells produce acetyl-CoA through a fundamentally different pathway than prototrophic yeast.
“cancer cells make acetyl-CoA via a fundamentally different pathway than prototrophic yeast”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Wellen et al., 2009 source
Not checked in the free run.
- Premisecitation
In HeLa cells, acetyl-CoA production needed for histone acetylation is attributed to ATP citrate lyase converting citrate into oxaloacetate and acetyl-CoA.
“the production of acetyl-CoA in HeLa cells necessary to drive histone acetylation has been attributed to the enzymatic conversion of citrate into oxaloacetate and acetyl-CoA via the ATP citrate lyase enzyme”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Wellen et al., 2009 source
Not checked in the free run.
- Interpretationreasoning
The coordinated induction of yeast growth genes by acetyl-CoA probably reflects an evolutionarily ancient pathway that links cell growth and division to nutritional state.
“This precisely orchestrated pattern of yeast growth gene induction in response to ambient levels of intracellular acetyl-CoA probably represents an evolutionarily ancient regulatory pathway allowing cells to properly link the commitment of cell growth and division to nutritional state.”
Quote in the paperSubstantial claim- Rests on an assumption: Histone and DNA chemical modifications are central to epigenetic control of gene expression.
- Interpretationreasoning
It remains unclear whether sirtuin activity is operatively linked to metabolic state through fluctuations in intracellular NAD+ levels.
“Thus it remains unclear whether sirtuin activity is operatively linked to metabolic state via fluctuations in the intracellular levels of NAD+.”
Quote in the paperSubstantial claim - Premisecitation
Histone methylation is a covalent modification that is as important as histone acetylation in determining the epigenetic state of chromatin.
“Histone methylation represents a covalent modification that is of equal importance to histone acetylation in defining the epigenetic state of chromatin (Kouzarides, 2002; Zhang and Reinberg, 2001).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Kouzarides, 2002 source
Not checked in the free run.
- cites Zhang and Reinberg, 2001
Not checked in the free run.
- Premisecitation
H3K4me2 and H3K4me3 marks lost upon threonine deprivation are part of a bivalent epigenetic state important for keeping developmental transcription factor genes repressed or poised for induction during embryogenesis.
“The H3K4me2 and H3K3me3 marks that disappear when mouse ESCs are deprived of threonine (Shyh-Chang et al., 2013) are part of a “bivalent” epigenetic state believed to be uniquely important for keeping the chromatin structure of genes encoding developmentally important transcription factors in a properly repressed/poised state for subsequent induction as a function of embryogenesis (Bernstein et al”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
MATIIα localizes to the nucleus.
“Cytological experiments revealed the nuclear localization of the MATIIα enzyme,”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Katoh et al., 2011 source
Not checked in the free run.
- Premisecitation
Chemical inhibition of TDH in mouse ESCs causes a precipitous drop in intracellular N5-MTHF.
“Not surprisingly, chemical inhibition of the TDH enzyme in mouse ESCs causes a precipitous drop in the level of intracellular N5-MTHF (Alexander et al., 2011).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Alexander et al., 2011 source
Not checked in the free run.
- Premisecitation
Chemical inhibition of TDH in mouse ESCs significantly lowers intracellular acetyl-CoA.
“When ESCs are exposed to a selective chemical inhibitor of the TDH enzyme, intracellular levels of acetyl-CoA drop significantly (Alexander et al., 2011).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Alexander et al., 2011 source
Not checked in the free run.
- Interpretationcitation
Association of MATIIα with MafK target genes may be required for transcriptional repression.
“the results of a variety of molecular biological experiments were interpreted to indicate that the association of the MATIIα methyltransferase enzyme with MafK target genes may be required for transcriptional repression.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Katoh et al., 2011 source
Not checked in the free run.
- Interpretationreasoning
The rise in AICAR after TDH inhibition is attributable to reduced mitochondrial glycine production.
“Increases in AICAR, a biosynthetic intermediate that awaits N5-MTHF-mediated one-carbon donation to continue along the pathway of purine biosynthesis, could likewise be attributed to attenuation in the production of mitochondrial glycine.”
Quote in the paperSubstantial claim - Interpretationcitation
The metabolic properties caused by high TDH expression in mouse ESCs cannot apply to human stem cells.
“As such, the unique metabolic properties engendered by copious expression of the TDH enzyme in mouse ESCs cannot apply to human stem cells.”
Quote in the paperSubstantial claim - Premisenone given
Mouse ESCs express exceptionally high levels of TDH, which catabolizes threonine into glycine and acetyl-CoA.
“As mentioned earlier in this review, mouse ESCs express exceptionally high levels of the TDH enzyme, which catabolizes threonine into glycine and acetyl-CoA (Figure 4).”
Quote in the paperSubstantial claim - Premisecitation
Threonine restriction dramatically impedes deposition of H3K4me2 and H3K4me3 marks on chromatin.
“Intriguingly, threonine restriction was observed to dramatically impede deposition of the H3K4me2 and H3K4me3 marks on chromatin.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Shyh-Chang et al., 2013 source
Not checked in the free run.
- Interpretationcitation
TDH-mediated threonine catabolism may be important for maintaining high SAM levels in mouse ESCs.
“More recent work on mouse ESCs has led to the conclusion that TDH-mediated catabolism of threonine might also be important for maintaining high levels of SAM (Shyh-Chang et al., 2013).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Shyh-Chang et al., 2013 source
Not checked in the free run.
- Rests on an assumption: Both histone and DNA methylation require SAM as the high-energy methyl donor.
- Premisecitation
LSD1 and LSD2 can influence H3K9 methylation and DNA methylation through multiprotein complexes or indirect effects of H3K4 methylation.
“LSD1 and its paralog LSD2 (also called KDM1B or AOF1) can also influence H3K9 methylation and DNA methylation, either due to their participation in multiprotein complexes that contain additional chromatin-modifying enzymes, including deacetylases and methyltransferases, or due to indirect effects of H3K4 methylation on recruitment of such enzymes (Ciccone et al., 2009; Lan et al., 2008; Wang et al”
Quote in the paperNot a substantial claim0 of 3 sources checked - Premisereasoning
LSD1 catalysis requires a protonated lysine epsilon amino group, restricting its activity to mono- and dimethylated H3K4.
“The chemical reaction catalyzed by LSD1 requires a protonated lysine epsilon amino group, thereby limiting its activity to monomethylated and dimethylated H3K4 (Figure 5).”
Quote in the paperNot a substantial claim - Premisecitation
LSD1 binds directly to PGC1α, PDK4, FATP1, and ATGL genes and represses their transcription in association with loss of H3K4 methylation.
“Specifically, LSD1 binds directly to genes such as PPARg coactivator-1α (PGC1α), PDK4, FATP1, and ATGL and represses their transcription associated with loss of H3K4 methylation (Hino et al., 2012).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Hino et al., 2012 source
Not checked in the free run.
- Interpretationreasoning
Mouse ESCs require the specialized TDH catabolic pathway to convert threonine into acetyl-CoA and glycine-dependent methylation capacity essential for nucleotide biosynthesis.
“it may reasonably be concluded that these cells require the specialized features of the TDH catabolic pathway to convert threonine into both acetyl-CoA and the glycine-dependent methylation capacity essential for the biosynthesis of nucleotides.”
Quote in the paperSubstantial claim - Premisecitation
Methionine is converted to SAM by MAT enzymes in an ATP-dependent reaction.
“The conversion of methionine to SAM is catalyzed in an ATP-dependent manner by methionine adenosyltransferase (MAT) enzymes (Sakata et al., 1993).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Sakata et al., 1993 source
Not checked in the free run.
- Rests on an assumption: Both histone and DNA methylation require SAM as the high-energy methyl donor.
- Premisereasoning
Mitochondrial glycine from TDH-mediated threonine degradation feeds the glycine cleavage enzyme complex that converts tetrahydrofolate to N5-MTHF.
“The latter catabolite of TDH-mediated degradation of threonine is known to feed the mitochondrial glycine cleavage enzyme complex responsible for converting tetrahydrofolate to N5-MTHF (Figure 4).”
Quote in the paperSubstantial claim - Premisecitation
Affinity chromatography with tagged MafK discovered its interaction with MATIIα.
“Affinity chromatography experiments employing a tagged version of the MafK protein led to the discovery of its interaction with MATIIα,”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Katoh et al., 2011 source
Not checked in the free run.
- Interpretationreasoning
Threonine catabolism is vitally important for ESCs to biosynthesize building blocks for DNA synthesis.
“it was straightforward to predict that catabolism of threonine is vitally important for ESCs to biosynthesize the required building blocks for DNA synthesis.”
Quote in the paperSubstantial claim - Premisecitation
Humans do not encode a functional TDH enzyme, unlike other primates, mammals, and perhaps all metazoans.
“Perplexingly, unique among all primates, mammals, and— perhaps—all metazoan species, humans do not encode a functional TDH enzyme (Edgar, 2002).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Edgar, 2002 source
Not checked in the free run.
- Premisecitation
DNA is methylated at the C5 position of cytosine.
“DNA itself is also subject to methylation on the C5 atom of cytosine (Bird, 2002).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Bird, 2002 source
Not checked in the free run.
- Interpretationreasoning
The rise in threonine after TDH inhibition is attributable to reduced activity of the enzyme that degrades it.
“The increase in threonine can logically be attributed to diminution in the activity of the enzyme that degrades it.”
Quote in the paperSubstantial claim - Premisecitation
MATIIα associates with the transcription factor MafK.
“A recent study has given evidence that one of the MAT isoforms, MATIIα, associates with a gene-specific transcription factor designated MafK.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Katoh et al., 2011 source
Not checked in the free run.
- Premisecitation
Increased H3K4 and H3K9 histone methylation has been documented in cells treated with hypoxia in vitro.
“Moreover, increased H3K4 and H3K9 histone methylation has been documented in cells treated with hypoxia in vitro (Johnson et al., 2008; Tausendschön et al., 2011; Zhou et al., 2010).”
Quote in the paperSubstantial claim0 of 3 sources checked - Interpretationreasoning
HIF provides another link between metabolism and epigenetics through transcriptional regulation of JmjC histone demethylases and other epigenetic modifiers.
“Therefore, HIF provides another link between metabolism and epigenetics through its transcriptional regulation of JmjC histone demethylases and other modifiers of epigenetic state.”
Quote in the paperSubstantial claim- Rests on an assumption: HIF synthesis is influenced by the PI3K-AKT-mTOR pathway sensing nutrients, while its degradation is controlled by EglN prolyl hydroxylases responding to oxygen and Krebs cycle intermediates.
- Premisecitation
Tumor-associated IDH mutations enable production of R-2-hydroxyglutarate, which accumulates to low millimolar levels in IDH mutant tumors.
“Tumor-associated IDH mutations unmask a latent ability of these enzymes to produce the R enantiomer of 2-hydroxyglutarate, which accumulates to low millimolar levels in IDH mutant tumors (Dang et al., 2009; Gross et al., 2010; Ward et al., 2010).”
Quote in the paperSubstantial claim0 of 3 sources checked - Interpretationcitation
TET-catalyzed oxidation of 5mC followed by decarboxylation or base excision is strongly suspected to contribute to DNA demethylation.
“TET-catalyzed oxidation of 5mC followed by decarboxylation or base excision is strongly suspected of contributing to DNA demethylation (Cortellino et al., 2011; He et al., 2011; Ito et al., 2011), yet there are currently conflicting reports regarding the effect of TET inactivation on global DNA methylation patterns in somatic cells (Figueroa et al., 2010; Ko et al., 2010; Yamazaki et al., 2012).”
Quote in the paperNot a substantial claim0 of 3 sources checked - Premisenone given
JmjC histone demethylases can demethylate trimethylated lysines and arginines, unlike LSD proteins.
“The JmjC histone demethylases, in contrast to LSD proteins, are capable of demethylating trimethylated lysines and arginines.”
Quote in the paperNot a substantial claim - Premisenone given
Somatic mutations in cytosolic IDH1 and mitochondrial IDH2 have been identified in gliomas, acute myelogenous leukemia, chondrosarcomas, and cholangiosarcomas.
“Somatic mutations affecting cytosolic IDH1 and mitochondrial IDH2 have been identified in gliomas, acute myelogenous leukemia, chondrosarcomas, and cholangiosarcomas.”
Quote in the paperNot a substantial claim - Premisecitation
mRNAs for multiple JmjC histone demethylase genes, including JMJD1A, JMJD2B, and JARIDC, are induced by hypoxia and HIF.
“Specifically, the messenger RNAs (mRNAs) for multiple JmjC histone demethylase genes, including JMJD1A (an H3K9 demethylase), JMJD2B (an H3K9 demethylase), and JARIDC (an H3K4 demethylase), are induced by hypoxia and HIF, conceivably to compensate for their diminished catalytic activity under low-oxygen conditions (Chervona and Costa, 2012; Xia et al., 2009) (Figure 6A).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Chervona and Costa, 2012
Not checked in the free run.
- cites Xia et al., 2009 source
Not checked in the free run.
- Premisenone given
Km values for these enzymes are typically determined under idealized in vitro conditions using purified enzymes without endogenous inhibitors such as fumarate, succinate, and reactive oxygen species.
“A caveat, however, is that such Km values are typically determined under idealized in vitro conditions using purified enzymes in the absence of endogenous inhibitory molecules such as fumarate, succinate, and reactive oxygen species.”
Quote in the paperSubstantial claim - Premisecitation
Intracellular 2-oxoglutarate levels are estimated to be in the low millimolar range, well above the Km values of JmjC histone demethylases and TET proteins determined to date.
“Intracellular 2-oxoglutarate levels are estimated to be in the low millimolar range, well above the 2-oxoglutarate Km values of the JmjC histone demethylases and TET proteins determined to date (Chowdhury et al., 2011; Pritchard, 1995).”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisenone given
Different JmjC histone demethylases prefer different histone methylation marks.
“Different JmjC histone demethylases exhibit preferences for different histone methylation marks.”
Quote in the paperNot a substantial claim - Premisecitation
EglN prolyl hydroxylases, which mark HIF for destruction, have O2 Km values at or near atmospheric oxygen levels, making their activity sensitive to oxygen changes within a physiologically relevant range.
“Certain 2-oxoglutarate-dependent dioxygenases, such as the EglN prolyl hydroxylases that mark the HIF transcription factor for destruction, have O2 Km values at or near atmospheric oxygen levels and hence their activity is sensitive to changes in oxygen availability within a physiologically relevant range (Hirsilä et al., 2003).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Hirsilä et al., 2003 source
Not checked in the free run.
- Premisecitation
Inactivating mutations in mitochondrial SDH complex subunits and FH have been identified in cancers, particularly familial paragangliomas and papillary renal cancers.
“Inactivating mutations affecting the mitochondrial succinate dehydrogenase (SDH) complex subunits and fumarate hydratase (FH) have been identified in cancers, particularly in familial paragangliomas and papillary renal cancers, respectively (Kaelin, 2009).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Kaelin, 2009 source
Not checked in the free run.
- Premisecitation
About 30 JmjC domain-containing histone demethylases and three TET proteins are 2-oxoglutarate-dependent dioxygenases.
“A number of chromatin-modifying enzymes, including the approximately 30 JmjC domain-containing histone demethylases and the three TET (ten-eleven translocation) proteins, are 2-oxoglutarate-dependent dioxygenases (Loenarz and Schofield, 2011) (Figure 5).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Loenarz and Schofield, 2011
Not checked in the free run.
- Rests on an assumption: 2-oxoglutarate-dependent dioxygenases require oxygen and Fe(II) in addition to 2-oxoglutarate.
- Premisecitation
Somatic mosaicism for IDH mutations causes Ollier Disease syndrome and Maffucci syndrome, characterized by endochondromas and spindle cell hemangiomas.
“Somatic mosaicism for such mutations causes Ollier Disease syndrome and Maffucci syndrome, which are characterized by the development of endochondromas and spindle cell hemangiomas (Amary et al., 2011; Pansuriya et al., 2011).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
TET proteins oxidize 5-methylcytosine to 5-hydroxymethylcytosine, 5-formylcytosine, and 5-carboxylcytosine.
“TET proteins can oxidize 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC), 5-formyl cytosine (5fC), and 5-carboxylcytosine (5caC) (He et al., 2011; Ito et al., 2011; Tahiliani et al., 2009).”
Quote in the paperSubstantial claim0 of 3 sources checked - Interpretationcitation
Indirect evidence suggests at least some JmjC histone demethylases could be oxygen sensitive.
“The O2 Km values for the JmjC histone demethylases and TET proteins are not known, although indirect evidence suggests that at least some of the former could be oxygen sensitive.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Chervona and Costa, 2012
Not checked in the free run.
- cites Xia et al., 2009 source
Not checked in the free run.
- Premisecitation
In model systems, many metabolic enzymes have in vivo Km values higher than their in vitro values and closer to cosubstrate concentrations.
“In model systems, many metabolic enzymes display Km values in vivo that are higher than their corresponding in vitro values and certainly closer to the concentrations of their cosubstrates (Bennett et al., 2009; Yuan et al., 2009).”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
These biochemical properties make 2-oxoglutarate-dependent dioxygenases potentially susceptible to carcinogenic metals such as nickel, arsenic, and chromium, which displace iron, cause oxidative stress, or both.
“These biochemical attributes render these enzymes potentially susceptible to carcinogenic metals such as nickel, arsenic, and chromium, which displace iron, contribute to oxidative stress, or do both (Chervona and Costa, 2012).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Chervona and Costa, 2012
Not checked in the free run.
- Rests on an assumption: 2-oxoglutarate-dependent dioxygenases require oxygen and Fe(II) in addition to 2-oxoglutarate.
- Rests on an assumption: These enzymes are sensitive to reactive oxygen species and their activity is enhanced by ascorbic acid.
- Premisereasoning
These mutations lead to marked accumulation of succinate and fumarate, respectively.
“These mutations lead to the marked accumulation of succinate and fumarate, respectively (Figure 6B).”
Quote in the paperSubstantial claim - Interpretationnone given
The functions of JmjC and TET proteins appear to be deregulated by altered metabolism under pathological conditions in specific cancers.
“The functions of these proteins do, however, appear to be deregulated as a result of altered metabolism under the pathological conditions found in the specific cancers described below.”
Quote in the paperSubstantial claim - Interpretationreasoning
Many epigenetic enzymes are potentially susceptible to changes in levels of cosubstrates and cofactors such as oxygen, ATP, acetyl-CoA, MTHF, SAM, NAD, FAD, and 2-oxoglutarate and are poised to respond to changes in nutrient intake and metabolism.
“Many epigenetic enzymes are potentially susceptible to changes in the levels of cosubstrates and cofactors such as oxygen, ATP, acetyl-CoA, MTHF, S-adenosylmethionine, NAD, FAD, and 2-oxoglutarate and are hence poised to respond to changes in nutrient intake and metabolism.”
Quote in the paperSubstantial claim- Rests on an assumption: Both histone and DNA methylation require SAM as the high-energy methyl donor.
- Rests on an assumption: FAD is derived from riboflavin and functions as a prosthetic group for certain oxidation-reduction enzymes.
- Rests on an assumption: 2-oxoglutarate-dependent dioxygenases require oxygen and Fe(II) in addition to 2-oxoglutarate.
- Premisenone given
IDH mutant tumors have been reported to show DNA hypermethylation changes consistent with TET2 inactivation.
“Moreover, IDH mutant tumors have been reported to display DNA hypermethylation changes consistent with TET2 inactivation.”
Quote in the paperSubstantial claim - Premisecitation
Animal studies suggest folate might increase cancer progression if given to nascent colon tumors.
“In this regard, animal studies suggest that folate might actually increase cancer progression if given to nascent tumors in the colon (Kim, 2004).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Kim, 2004 source
Not checked in the free run.
- Premisecitation
HIF1α accumulates in SDH and FH mutant tumors, presumably due to inhibition of EglN prolyl hydroxylases.
“For example, the HIF1α transcription factor accumulates in SDH and FH mutant tumors, presumably due to inhibition of the EglN prolyl hydroxylases (Dahia et al., 2005; Isaacs et al., 2005; Pollard et al., 2005, 2007; Selak et al., 2005).”
Quote in the paperNot a substantial claim0 of 3 sources checked - Premisecitation
Intervention trials have failed to show reduced cancer risk in individuals randomized to folic acid supplements compared to controls.
“Disappointingly, however, intervention trials have failed to demonstrate a reduction of cancer risk in individuals randomized to receive folic acid supplements compared to controls (Andreeva et al., 2012; Cole et al., 2007; Song et al., 2012; Zhang et al., 2008).”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation
Observational studies in humans are consistent with a possible role of nutrition in epigenetics and disease.
“Observational studies in humans are also consistent with a possible role of nutrition in epigenetics and disease.”
Quote in the paperNot a substantial claim - Premisecitation
Changes in glucose and glucose metabolism can leave lasting epigenetic marks.
“There is also evidence that changes in glucose and glucose metabolism can leave lasting epigenetic marks (Park et al., 2012; Pirola et al., 2010).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Interpretationreasoning
Inactivation of TET2 probably contributes to leukemic transformation caused by mutant IDH and its R-2HG oncometabolite.
“Therefore, inactivation of TET2 probably contributes to leukemic transformation at the hands of mutant IDH and the R-2HG “oncometabolite” it produces.”
Quote in the paperSubstantial claim - Premisenone given
Nutrition is among the relevant exposures.
“Among the relevant exposures are exposures related to nutrition.”
Quote in the paperSubstantial claim - Premisecitation
R-2HG, succinate, and fumarate can inhibit multiple 2-oxoglutarate-dependent dioxygenases, including JmjC histone demethylases and TET proteins, at sufficiently high concentrations.
“R-2HG, succinate, and fumarate are all capable of inhibiting multiple 2-oxoglutarate-dependent dioxygenases, including the JmjC histone demethylases and TET proteins, when present at sufficiently high concentrations (Figure 6B) (Cervera et al., 2009; Chowdhury et al., 2011; Figueroa et al., 2010; Koivunen et al., 2012; Lu et al., 2012; Smith et al., 2007; Turcan et al., 2012; Xiao et al., 2012; Xu”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation
Many bioactive molecules in food and herbs, in addition to folate, can influence epigenetics and have been proposed as potential chemopreventative agents.
“There are many bioactive molecules present in food and herbs, in addition to folate, that are capable of influencing epigenetics and that have been touted as potential chemopreventative agents. Examples include various B vitamins, retinoic acid, vitamin D3, reservatrol, genistein and daidzein, epigallocatechin-3-gallate (EGCG), and curcumin (Gerhauser, 2013; Stefanska et al., 2012).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Several 2-oxoglutarate-dependent chromatin enzymes, including UTX, JARID1C, and TET2, are targets of inactivating mutations in cancer, making them candidates for pathogenic inhibition by succinate, fumarate, and R-2HG.
“A number of 2-oxoglutarate-dependent enzymes that act on chromatin are themselves targets of inactivating mutations in cancer, including the UTX H3K27 demethylase (also called KDM6A), JARID1C H3K4 demethylase (KDM5C), and TET2, making them attractive candidates for pathogenically relevant inhibition by succinate, fumarate, and R-2HG (Abdel-Wahab et al., 2009; Dalgliesh et al., 2010; Tefferi et al”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation
Genetic variation in genes linked to one-carbon metabolism, including MTHFD1, FTHFD, MTHFR, methionine synthase, and glycine-N-methyltransferase, is linked to disease phenotypes including cancer and developmental defects.
“Genetic variation in a number of genes linked to one-carbon metabolism, including methylenetetrahydrofolate dehydrogenase 1, FTHF dehydrogenase, 5–10 methylene-THF reductase, methionine synthase, and glycine-N-methyltransferase, has been linked to a variety of disease phenotypes including cancer and developmental defects (Stover, 2011).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Stover, 2011 source
Not checked in the free run.
- Premisecitation
Individuals conceived during famine have decreased DNA methylation at specific loci such as IGF2, associated with increased risk of obesity, dyslipidemia, and insulin resistance later in life.
“For example, studies of individuals conceived during famine conditions have revealed decreased DNA methylation of specific loci, such as the IGF2 gene, associated with an increased risk of obesity, dyslipidemia, and insulin resistance later in life (Dominguez-Salas et al., 2012).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Dominguez-Salas et al., 2012 source
Not checked in the free run.
- Premisenone given
Biomarkers or dietary histories indicating nutritional deficiencies associated with one-carbon metabolism defects, such as folate deficiency, are frequently associated with increased cancer risk in epidemiological studies.
“Biomarkers or dietary histories indicative of nutritional deficiencies associated with defects in one-carbon metabolism (for example, folate deficiency) have frequently been associated with an increased risk of cancer in epidemiological studies.”
Quote in the paperSubstantial claim - Premisecitation
Studies in rodents and sheep confirmed that availability of nutrients required for one-carbon metabolism at conception and during pregnancy can induce epigenetically driven phenotypes in offspring.
“Studies in rodents and sheep have confirmed that the availability of nutrients required for one-carbon metabolism (for example, folate, choline, methionine, and betaine, as well as selected B vitamins) at the time of conception and during pregnancy can induce epigenetically driven phenotypes in their offspring (Dolinoy et al., 2007; Sinclair et al., 2007; Waterland et al., 2006; Wolff et al., 1998”
Quote in the paperSubstantial claim0 of 3 sources checked
- May combine two claims. 28
- Classified as probably not a substantial claim. 9
- The quote only partly states this claim. 1
May combine two claims.
FindingcitationUndifferentiated mouse embryonic stem cells express threonine dehydrogenase at levels more than 1,000-fold higher than other mouse cells or tissues, and the encoding gene is repressed immediately upon differentiation.
“Undifferentiated mouse ESCs express levels of TDH upward of 1,000-fold higher relative to any other source of mouse cells or tissues, and the gene encoding TDH is stringently repressed immediately upon induction of ESC differentiation”
Quote in the paperSubstantial claimMay combine two claims.
FindingcitationIn wild-type mouse liver, NAD+ abundance shows two ultradian peaks and troughs per 24 hr cycle, with peak-to-trough fluctuation of 20-30%.
“When NAD+ levels were measured in liver tissue of wild-type mice, two ultradian sets of peaks and troughs of NAD+ abundance were observed per 24 hr cycle (Ramsey et al., 2009). The peak-to-trough fluctuation in NAD+ abundance varied by 20%–30%, as reported in the latter study.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ramsey et al., 2009 source
Not checked in the free run.
May combine two claims.
FindingcitationAdministering β-hydroxybutyrate to mice via an intraperitoneal pump enhanced H3K9 and H3K14 acetylation, induced FOXO3A-regulated genes, and increased resistance to oxidative stress.
“By administering β-hydroxybutyrate to laboratory mice via an intraperitoneal pump, Shimazu and colleagues were able to demonstrate enhancement of H3K9 and H3K14 acetylation, induced expression of FOXO3A–regulated genes, and resistance to oxidative stress.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Shimazu et al., 2013 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Premisenone givenThreonine can be converted catabolically into acetyl-CoA by a mitochondrial threonine dehydrogenase that is expressed uniquely in mouse embryonic stem cells.
“Acetyl-CoA can also be produced catabolically from threonine via a mitochondrial threonine dehydrogenase enzyme uniquely expressed in mouse embryonic stem cells”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisereasoningAcetyl-CoA can be generated through multiple catabolic and anabolic routes.
“Acetyl-CoA can be produced through a variety of metabolic pathways, both catabolic and anabolic”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationThe yeast growth gene battery closely matches genes induced by c-Myc in mammalian cells, which are reported to depend on both c-Myc and GCN5/SAGA.
“This yeast growth gene battery matches closely with the genes induced by the c-Myc oncoprotein in mammalian cells”
Quote in the paperSubstantial claim0 of 3 sources checkedMay combine two claims.
PremisereasoningIn metazoan cells, mitochondrial citrate is exported to the cytoplasm by the malate-citrate antiporter and converted by ATP citrate lyase into acetyl-CoA and oxaloacetate, supplying cytoplasmic acetyl-CoA for lipid synthesis.
“metazoan cells have evolved the malate-citrate antiporter system to move mitochondrial citrate to the cytoplasm, where it can combine with ATP and CoA to be converted to acetyl-CoA and oxaloacetate via the ATP citrate lyase enzyme, thereby affording a cytoplasmic pool of acetyl-CoA for lipid biosynthesis.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationSIRT3 and SIRT6 are encoded by genes with tumor-suppressor activity.
“the genes encoding SIRT3 and SIRT6 are tumor suppressors”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
PremisereasoningSAM contains the active methyl donor group used by most methyltransferase enzymes.
“S-adenosylmethionine (SAM) contains the active methyl donor group utilized by most methyltransferase enzymes”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationNAD+ levels fluctuate with the circadian cycle, instructing nuclear sirtuins to control chromatin epigenetic state.
“NAD+ levels fluctuate as a function of the circadian cycle, thereby instructing nuclear sirtuin enzymes to control the epigenetic state of chromatin in an NAD+-regulated manner.”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
InterpretationreasoningSirtuin enzymes oppose protein acetylation, and protein acetylation can be influenced by intracellular acetyl-CoA levels.
“sirtuin enzymes sit in diametric opposition to protein acetylating and that protein acetylation can be influenced by intracellular levels of acetyl-CoA.”
Quote in the paperSubstantial claim- Rests on an assumption: Histone and DNA chemical modifications are central to epigenetic control of gene expression.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisereasoningThe activated methyl cycle regenerates methionine by transferring a methyl group from N5-MTHF to homocysteine.
“The activated methyl cycle can then be looped back via the transfer of a methyl group from N5-MTHF to homocysteine, regenerating methionine.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationSirtuin deacetylases require NAD+ and produce O-acetyl-ADP-ribose, the deacetylated substrate, and nicotinamide.
“those that are NAD+-dependent, yielding O-acetyl-ADP-ribose, the deacetylated substrate, and nicotinamide as products”
Quote in the paperNot a substantial claim0 of 3 sources checkedMay combine two claims.
Interpretationcitationβ-hydroxybutyrate can fuel metabolic adaptation to starvation and help sustain a protective epigenetic state by inhibiting NAD+-independent histone deacetylases.
“These data provide evidence that a distinct metabolite, β-hydroxybutyrate, is able not only to fuel metabolic adaptation to starvation but also to help sustain a protective epigenetic state by inhibiting the activities of NAD+-independent histone deacetylase enzymes.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Shimazu et al., 2013 source
Not checked in the free run.
- Rests on an assumption: Histone and DNA chemical modifications are central to epigenetic control of gene expression.
May combine two claims.
PremisecitationAcetylation of AceCS2 on a specific lysine inhibits its ability to convert acetate into acetyl-CoA, and this regulatory scheme is conserved from Salmonella to mammals.
“AceCS2 is acetylated on a specific lysine residue that inhibits the ability of the enzyme to convert acetate into acetyl-CoA, a regulatory scheme conserved from Salmonella to mammals”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenSAM is produced by condensation of methionine and ATP during the first of nine steps converting methionine to succinyl-CoA.
“SAM is produced by the condensation of methionine and ATP during the first of nine steps required for the conversion of methionine to succinyl-CoA.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningFor AceCS2 and PGC1α, ample nutrients inhibit their activities through acetyl-CoA-mediated acetylation, which is counterbalanced by SIRT3 and SIRT1.
“access to ample nutrients can simplistically be understood to inhibit the activities of the two proteins via acetyl-CoA-mediated acetylation. This inhibition, in turn, can be respectively counterbalanced by the mitochondrial SIRT3 and nuclear SIRT1 enzymes.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisenone givenEnzyme-catalyzed donation of SAM's methyl group to an acceptor yields SAH, which is hydrolyzed to homocysteine and adenosine.
“Enzyme-catalyzed donation of the methyl group of SAM to an acceptor macromolecule yields S-adenosylhomocysteine (SAH), which, in turn, is hydrolyzed to homocysteine and adenosine.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationTDH inhibition in ESCs increases intracellular threonine and AICAR.
“Simultaneous increases in the intracellular abundance of threonine and 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) were observed upon TDH inhibition in ESCs.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Alexander et al., 2011 source
Not checked in the free run.
May combine two claims. The quote only partly states this claim.
PremisecitationThreonine deprivation selectively affects H3K4me2 and H3K4me3 but not H3K4me1, H3K9me3, H3K27me3, H3K36me3, or H3K79me3 marks.
“These impediments were selective; threonine deprivation had no effect on the deposition of H3K4me1, H3K9me3, H3K27me3, H3K36me3, or H3K79me3 marks on histone tails.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Shyh-Chang et al., 2013 source
Not checked in the free run.
May combine two claims.
PremisecitationLSD1 is a nuclear FAD-dependent enzyme that demethylates methylated H3K4 in vitro and in vivo, establishing histone methylation as dynamic and reversible.
“In a landmark paper, Yang Shi and coworkers showed that LSD1 (also called KDM1A or AOF2) is a nuclear FAD-dependent enzyme capable of demethylating methylated H3K4 both in vitro and in vivo, thereby establishing that histone methylation is a dynamic, reversible process (Shi et al., 2004).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Shi et al., 2004 source
Not checked in the free run.
- Rests on an assumption: FAD is derived from riboflavin and functions as a prosthetic group for certain oxidation-reduction enzymes.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMafK can either repress or activate gene expression depending on its heterodimeric partner.
“The latter protein is a small bZip transcription factor that, depending upon its heterodimeric partner, can either repress or activate gene expression (Hintze et al., 2007; Igarashi and Sun, 2006; Muto et al., 1998; Ochiai et al., 2006; Zhang et al., 2006).”
Quote in the paperNot a substantial claim0 of 3 sources checkedMay combine two claims.
PremisecitationLSD1 regulates mitochondrial respiration and energy expenditure.
“LSD1, in turn, regulates mitochondrial respiration and energy expenditure.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Hino et al., 2012 source
Not checked in the free run.
May combine two claims.
PremisecitationIntracellular fumarate and succinate concentrations are estimated to be in the high micromolar and low millimolar range, respectively.
“In this regard, intracellular fumarate and succinate concentrations are estimated to be in the high micromolar and low millimolar range, respectively (Johnson et al., 2008).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Johnson et al., 2008 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningThis presumably allows such enzymes to respond to changes in concentrations of available agonists and antagonists.
“This presumably allows such enzymes to respond to changes in the concentrations of available agonists and antagonists.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationCollagen prolyl hydroxylases have very low O2 Km, presumably to function in poorly vascularized wounds.
“By contrast, the collagen prolyl hydroxylases have very low O2 Km, presumably so that they can function in environments such as poorly vascularized wounds (Hirsilä et al., 2003).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hirsilä et al., 2003 source
Not checked in the free run.
May combine two claims.
Premisecitation5hmC in the nervous system is associated with actively transcribed genes and recognized by MeCP2, which is inactivated in Rett syndrome.
“5hmC in the nervous system is associated with actively transcribed genes and is recognized by the histone-reader protein MeCP2, which is mutationally inactivated in the neurological disorder of Rett syndrome (Mellén et al., 2012).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Mellén et al., 2012 source
Not checked in the free run.
May combine two claims.
InterpretationreasoningThe rapid reversal of R-2HG effects suggests either that these phenotypes are not due to epigenetic targets of R-2HG or that R-2HG-induced epigenetic changes are surprisingly dynamic.
“This suggests either that these phenotypes are not due to epigenetic targets of R-2HG or that R-2HG-induced epigenetic changes are surprisingly dynamic.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningThese metabolites appear to cause cancer by affecting various 2-oxoglutarate-dependent dioxygenases, including those linked to DNA and histone methylation, and therefore have potential to alter the epigenome.
“These metabolites appear to cause cancer by affecting the behavior of various 2-oxoglutarate-dependent dioxygenases, including dioxygenases linked to DNA and histone methylation, and therefore have the potential to alter the epigenome.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationTET2 inactivation is sufficient to promote hematopoietic stem cell self-renewal and block differentiation.
“In addition, TET2 inactivation is sufficient to promote hematopoietic stem cell self-renewal and to block differentiation (Figueroa et al., 2010; Li et al., 2011; Moran-Crusio et al., 2011; Noushmehr et al., 2010; Turcan et al., 2012; Losman et al., 2013).”
Quote in the paperSubstantial claim0 of 3 sources checkedMay combine two claims.
PremisereasoningSDH, FH, and IDH mutations cause accumulation of succinate, fumarate, and R-2HG, respectively.
“In summary, SDH, FH, and IDH mutations cause the accumulation of succinate, fumarate, and R-2HG, respectively.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationDeletion of HIF1α worsens pathological changes in mice lacking FH, suggesting HIF1α normally constrains rather than promotes FH-defective tumors.
“Deletion of HIF1α, however, worsened the pathological changes observed in mice engineered to lack FH, suggesting that it normally constrains, rather than promotes, the emergence of FH-defective tumors (Adam et al., 2011).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Adam et al., 2011 source
Not checked in the free run.
May combine two claims.
PremisecitationTET2 and IDH mutations are both found in AML and are mutually exclusive, consistent with R-2HG from mutant IDH providing an alternative way to inactivate TET2.
“In this regard, TET2 and IDH mutations are both found in acute myelogenous leukemia and are mutually exclusive, consistent with the idea that R-2HG produced by mutant IDH provides an alterative means of inactivating TET2 (Figueroa et al., 2010).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Figueroa et al., 2010 source
Not checked in the free run.
May combine two claims.
InterpretationreasoningThe failure of folic acid trials might suggest that folate deficiency correlates with but does not cause cancer, or that folate is important only during an early time window before or during tumor initiation.
“This might suggest that folate deficiency correlates with, but does not cause, cancer or that folate is important during an early time window, perhaps occurring at an early age and prior to or during tumor initiation, but not thereafter.”
Quote in the paperSubstantial claimMay combine two claims.
Premisenone givenIncreasing evidence indicates that early exposures, including intrauterine exposures, can lead to lasting epigenetic changes and that epigenetic differences can influence many phenotypes, including disease risk.
“There is increasing evidence that early exposures, including intrauterine exposures, can lead to lasting epigenetic changes and that epigenetic differences can influence many phenotypes, including the risk of disease.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationR-2HG is sufficient to promote cytokine independence and block differentiation of hematopoietic cells in vitro, and these effects are rapidly reversed upon R-2HG withdrawal.
“Interestingly, R-2HG is sufficient to promote cytokine independence and block differentiation of hematopoietic cells in vitro and these effects are fairly rapidly reversed upon R-2HG withdrawal (Losman et al., 2013; K. Yen, personal communication).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Losman et al., 2013 source
Not checked in the free run.
- cites K. Yen, personal communication
Not checked in the free run.
The paper relies on this without support.
Histone and DNA chemical modifications are central to epigenetic control of gene expression.
“Chemical modifications of histones and DNA, such as histone methylation, histone acetylation, and DNA methylation, play critical roles in epigenetic gene regulation.”
The paper relies on this without support.
Cancer can arise from mutations in the metabolic enzymes SDH, FH, and IDH.
“This knowledge provides a conceptual foundation for understanding how mutations in the metabolic enzymes SDH, FH, and IDH can result in cancer”
The paper relies on this without support.
Both histone and DNA methylation require SAM as the high-energy methyl donor.
“Both histone and DNA methylation require SAM as the high-energy methyl donor (Figure 3).”
The paper relies on this without support.
FAD is derived from riboflavin and functions as a prosthetic group for certain oxidation-reduction enzymes.
“Flavin adenine dinucleotide (FAD) is derived from the vitamin riboflavin (vitamin B2) and functions as the prosthetic group for certain oxidation-reduction enzymes.”
The paper relies on this without support.
Riboflavin is phosphorylated by riboflavin kinase to FMN, which is converted to FAD by FAD synthetase.
“Riboflavin is phosphorylated by riboflavin kinase to generate riboflavin 5′-phosphate (sometimes called flavin monucleotide or FMN), which is then converted to FAD by FAD synthetase (also called FMN adenyl-transferase).”
The paper relies on this without support.
Riboflavin kinase appears rate limiting for FAD production.
“The former enzyme appears to be rate limiting for FAD production.”
The paper relies on this without support.
FAD is produced in mitochondria.
“FAD is produced in mitochondria.”
The paper relies on this without support.
2-oxoglutarate-dependent dioxygenases require oxygen and Fe(II) in addition to 2-oxoglutarate.
“2-oxoglutarate-dependent dioxygenases require oxygen and Fe (II) in addition to 2-oxoglutarate (also called α-ketoglutarate).”
The paper relies on this without support.
2-oxoglutarate is decarboxylated to succinate during the oxidation reaction.
“The latter metabolite is decarboxylated to succinate during the oxidation reaction (Figure 5).”
The paper relies on this without support.
These enzymes are sensitive to reactive oxygen species and their activity is enhanced by ascorbic acid.
“These enzymes are also sensitive to reactive oxygen species and their activity is enhanced in the presence of ascorbic acid.”
The paper relies on this without support.
HIF synthesis is influenced by the PI3K-AKT-mTOR pathway sensing nutrients, while its degradation is controlled by EglN prolyl hydroxylases responding to oxygen and Krebs cycle intermediates.
“HIF synthesis is influenced by the PI3K-AKT-mTOR pathway, which senses nutrients such as glucose and amino acids, while its degradation is under the control of the EglN prolyl hydroxylases, which respond to changes in oxygen and different Krebs cycle intermediates (Figure 6A).”
The paper relies on this without support.
2-oxoglutarate is produced from isocitrate in mitochondria by IDH2 and IDH3 in the TCA cycle and can also be generated from several amino acids including arginine, proline, histidine, and glutamine.
“2-oxoglutarate is produced from isocitrate in the mitochondria by the action of isocitrate dehydrogenases 2 and 3 (IDH2 and IDH3) in the TCA cycle and can also be generated from several amino acids including arginine, proline, histidine, and glutamine, which can be converted to glutamic acid and transaminated to produce 2-oxoglutarate.”
The paper relies on this without support.
2-oxoglutarate generated in the TCA cycle is converted to succinyl CoA by the 2-oxoglutarate dehydrogenase complex and is consumed during conversion of cysteine and lysine to pyruvate and acetyl-CoA.
“2-oxoglutarate generated in the course of the TCA cycle is converted to succinyl CoA by the action of the 2-oxoglutarate dehydrogenase complex and is also consumed during the conversion of cysteine and lysine to pyruvate and acetyl-CoA, respectively.”
The paper relies on this without support.
2-oxoglutarate generated in mitochondria can enter the cytosol via specific transporters such as the malate-2-oxoglutarate antiporter.
“2-oxoglutarate generated in the mitochondria can enter the cytosol, either as 2-oxoglutarate or after transamination to produce glutamic acid, via specific transporter proteins such as the malate-2-oxoglutarate antiporter, which participates in the malate-aspartate shuttle.”
The paper relies on this without support.
IDH1 resides in the cytosol and peroxisomes and provides an alternative source for nonmitochondrial 2-oxoglutarate.
“A third IDH paralog, IDH1, resides in the cytosol and peroxisomes and provides an alternative source for nonmitochondrial 2-oxoglutarate.”
The paper relies on this without support.
Altered epigenetics is believed to play a part in diseases including diabetes, obesity, dyslipidemia, hypertension, and neurodegeneration.
“Altered epigenetics is believed to play a part in a variety of diseases in addition to cancer, including diabetes, obesity, dyslipidemia, hypertension, and neurodegeneration.”
The paper relies on this without support.
Diet influences one-carbon metabolism, which plays an important role in DNA and histone methylation and in disease risk.
“In this regard, particular attention has been paid to the influence of diet on one-carbon metabolism, which plays an important role in DNA and histone methylation and in risk of disease.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Metabolic intermediates of the TCA cycle affect epigenetic control of gene expression by regulating histone and DNA modifications.
“metabolic intermediates of the TCA cycle affect epigenetic-mediated control of gene expression through regulating the modification of histones and DNA 137,138”
From Inside and out: the activities of senescence in cancer (2014) · cites this paper as [137]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Threonine-sensitive histone mark changes from H3K4me3 to H3K3me3
MinorOne passage identifies H3K4me3 as a mark whose deposition is impaired by threonine restriction, but the next identifies H3K3me3 as the mark that disappears alongside H3K4me2. The two passages give different identities for the affected mark.
“The H3K4me2 and H3K3me3 marks that disappear when mouse ESCs are deprived of threonine”
“Intriguingly, threonine restriction was observed to dramatically impede deposition of the H3K4me2 and H3K4me3 marks on chromatin.”
Cites
DNA methylation patterns and epigenetic memory
Bird, A. (2002) · Genes & Development · doi:10.1101/gad.947102 · Cited by 7,124 · see citing works
Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
Tahiliani, M., Koh, K. P., Shen, Y., Pastor, W. A., Bandukwala, H., Brudno, Y., Agarwal, S., Iyer, L. M., Liu, D. R., Aravind, L., et al. (2009) · Science · doi:10.1126/science.1170116 · Cited by 5,836 · see citing works
A bivalent chromatin structure marks key developmental genes in embryonic stem cells
Bernstein, B. E., Mikkelsen, T. S., Xie, X., Kamal, M., Huebert, D. J., Cuff, J., Fry, B., Meissner, A., Wernig, M., Plath, K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.041 · Cited by 5,361 · see citing works
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154 · see citing works
Histone demethylation mediated by the nuclear amine oxidase homolog LSD1
Shi, Y., Lan, F., Matson, C., Mulligan, P., Whetstine, J. R., Cole, P. A., Casero, R. A., & Shi, Y. (2004) · Cell · doi:10.1016/j.cell.2004.12.012 · Cited by 4,051 · see citing works
Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine
Ito, S., Shen, L., Dai, Q., Wu, S. C., Collins, L. B., Swenberg, J. A., He, C., & Zhang, Y. (2011) · Science · doi:10.1126/science.1210597 · Cited by 3,451 · see citing works
Cancer epigenetics: from mechanism to therapy
Dawson, M. A., & Kouzarides, T. (2012) · Cell · doi:10.1016/j.cell.2012.06.013 · Cited by 3,203 · see citing works
Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1
Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., Spiegelman, B. M., & Puigserver, P. (2005) · Nature · doi:10.1038/nature03354 · Cited by 3,160 · see citing works
Xu, W., Yang, H., Liu, Y., Yang, Y., Wang, P., Kim, S.-H., Ito, S., Yang, C., Wang, P., Xiao, M.-T., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.12.014 · Cited by 2,875 · see citing works
Tet-Mediated Formation of 5-Carboxylcytosine and Its Excision by TDG in Mammalian DNA
He, Y., Li, B.-Z., Li, Z., Liu, P., Wang, Y., Tang, Q., Ding, J., Jia, Y., Chen, Z., Li, L., et al. (2011) · Science · doi:10.1126/science.1210944 · Cited by 2,776 · see citing works
Figueroa, M. E., Abdel-Wahab, O., Lu, C., Ward, P. S., Patel, J., Shih, A., Li, Y., Bhagwat, N., Vasanthakumar, A., Fernandez, H. F., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.11.015 · Cited by 2,766 · see citing works
Haberland, M., Montgomery, R. L., & Olson, E. N. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2485 · Cited by 2,541 · see citing works
Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma
Noushmehr, H., Weisenberger, D. J., Diefes, K., Phillips, H. S., Pujara, K., Berman, B. P., Pan, F., Pelloski, C. E., Sulman, E. P., Bhat, K. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.03.017 · Cited by 2,337 · see citing works
ATP-citrate lyase links cellular metabolism to histone acetylation
Wellen, K. E., Hatzivassiliou, G., Sachdeva, U. M., Bui, T. V., Cross, J. R., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1164097 · Cited by 2,298 · see citing works
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase
Selak, M. A., Armour, S. M., MacKenzie, E. D., Boulahbel, H., Watson, D. G., Mansfield, K. D., Pan, Y., Simon, M. C., Thompson, C. B., & Gottlieb, E. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.11.022 · Cited by 2,108 · cited 1× · see citing works
“For example, the HIF1a transcription factor accumulates in SDH and FH mutant tumors, presumably due to inhibition of the EglN prolyl hydroxylases (Dahia et al., 2005; Isaacs et al., 2005; Pollard et al., 2005, 2007; Selak et al., 2005).”
Mammalian Sirtuins: Biological Insights and Disease Relevance
Haigis, M. C., & Sinclair, D. A. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092250 · Cited by 2,085 · see citing works
Ward, P. S., Patel, J., Wise, D. R., Abdel-Wahab, O., Bennett, B. D., Coller, H. A., Cross, J. R., Fantin, V. R., Hedvat, C. V., Perl, A. E., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.01.020 · Cited by 2,020 · cited 1× · see citing works
“unmask a latent ability of these enzymes to produce the R enantiomer of 2-hydroxyglutarate, which accumulates to low millimolar levels in IDH mutant tumors (Dang et al., 2009; Gross et al., 2010; Ward et al., 2010).”
IDH mutation impairs histone demethylation and results in a block to cell differentiation
Lu, C., Ward, P. S., Kapoor, G. S., Rohle, D., Turcan, S., Abdel-Wahab, O., Edwards, C. R., Khanin, R., Figueroa, M. E., Melnick, A., et al. (2012) · Nature · doi:10.1038/nature10860 · Cited by 1,985 · see citing works
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
Turcan, S., Rohle, D., Goenka, A., Walsh, L. A., Fang, F., Yilmaz, E., Campos, C., Fabius, A. W. M., Lu, C., Ward, P. S., et al. (2012) · Nature · doi:10.1038/nature10866 · Cited by 1,974 · see citing works
Absolute metabolite concentrations and implied enzyme active site occupancy in Escherichia coli
Bennett, B. D., Kimball, E. H., Gao, M., Osterhout, R., Van Dien, S. J., & Rabinowitz, J. D. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.186 · Cited by 1,830 · see citing works
Suppression of Oxidative Stress by β-Hydroxybutyrate, an Endogenous Histone Deacetylase Inhibitor
Shimazu, T., Hirschey, M. D., Newman, J., He, W., Shirakawa, K., Le Moan, N., Grueter, C. A., Lim, H., Saunders, L. R., Stevens, R. D., et al. (2013) · Science · doi:10.1126/science.1227166 · Cited by 1,777 · see citing works
Mutation in <i>TET2</i> in Myeloid Cancers
Delhommeau, F., Dupont, S., Valle, V. D., James, C., Trannoy, S., Massé, A., Kosmider, O., Le Couedic, J.-P., Robert, F., Alberdi, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810069 · Cited by 1,776 · see citing works
Functions of Site-Specific Histone Acetylation and Deacetylation
Shahbazian, M. D., & Grunstein, M. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.052705.162114 · Cited by 1,635 · see citing works
Zhang, Y., & Reinberg, D. (2001) · Genes & Development · doi:10.1101/gad.927301 · Cited by 1,534 · see citing works
Recent progress in the biology and physiology of sirtuins
Finkel, T., Deng, C., & Mostoslavsky, R. (2009) · Nature · doi:10.1038/nature08197 · Cited by 1,484 · see citing works
Dolinoy, D. C., Huang, D., & Jirtle, R. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703739104 · Cited by 1,369 · see citing works
Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation
Moran-Crusio, K., Reavie, L., Shih, A., Abdel-Wahab, O., Ndiaye-Lobry, D., Lobry, C., Figueroa, M. E., Vasanthakumar, A., Patel, J., Zhao, X., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.06.001 · Cited by 1,339 · see citing works
Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2
Ko, M., Huang, Y., Jankowska, A. M., Pape, U. J., Tahiliani, M., Bandukwala, H. S., An, J., Lamperti, E. D., Koh, K. P., Ganetzky, R. D., et al. (2010) · Nature · doi:10.1038/nature09586 · Cited by 1,294 · see citing works
Circadian Control of the NAD <sup>+</sup> Salvage Pathway by CLOCK-SIRT1
Nakahata, Y., Sahar, S., Astarita, G., Kaluzova, M., & Sassone-Corsi, P. (2009) · Science · doi:10.1126/science.1170803 · Cited by 1,198 · see citing works
Xiao, M., Yang, H., Xu, W., Ma, S., Lin, H., Zhu, H., Liu, L., Liu, Y., Yang, C., Xu, Y., et al. (2012) · Genes & Development · doi:10.1101/gad.191056.112 · Cited by 1,188 · cited 1× · see citing works
“R-2HG, succinate, and fumarate are all capable of inhibiting multiple 2-oxoglutarate-dependent dioxygenases, including the JmjC histone demethylases and TET proteins, when present at sufficiently high concentrations (Figure 6B) (Cervera et al., 2009; Chowdhury et al., 2011; Figueroa et al., 2010; Koivunen et al., 2012…”
Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes
Dalgliesh, G. L., Furge, K., Greenman, C., Chen, L., Bignell, G., Butler, A., Davies, H., Edkins, S., Hardy, C., Latimer, C., et al. (2010) · Nature · doi:10.1038/nature08672 · Cited by 1,173 · cited 1× · see citing works
“A number of 2-oxoglutarate-dependent enzymes that act on chromatin are themselves targets of inactivating mutations in cancer, including the UTX H3K27 demethylase (also called KDM6A), JARID1C H3K4 demethylase (KDM5C), and TET2, making them attractive candidates for pathogenically relevant inhibition by succinate, fuma…”
Circadian Clock Feedback Cycle Through NAMPT-Mediated NAD <sup>+</sup> Biosynthesis
Ramsey, K. M., Yoshino, J., Brace, C. S., Abrassart, D., Kobayashi, Y., Marcheva, B., Hong, H.-K., Chong, J. L., Buhr, E. D., Lee, C., et al. (2009) · Science · doi:10.1126/science.1171641 · Cited by 1,126 · see citing works
Histone acetyltransferase complexes: one size doesn't fit all
Lee, K. K. W., & Workman, J. L. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2145 · Cited by 1,091 · see citing works
Maternal epigenetics and methyl supplements affect agouti gene expression in A vy /a mice
Wolff, G. L., Kodell, R. L., Moore, S. R., & Cooney, C. A. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.11.949 · Cited by 1,057 · see citing works
Sodium butyrate inhibits histone deacetylation in cultured cells
Candido, E. (1978) · Cell · doi:10.1016/0092-8674(78)90305-7 · Cited by 1,036 · see citing works
The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases
Chowdhury, R., Yeoh, K. K., Tian, Y., Hillringhaus, L., Bagg, E. A., Rose, N. R., Leung, I. K. H., Li, X. S., Woon, E. C. Y., Yang, M., et al. (2011) · The EMBO Reports · doi:10.1038/embor.2011.43 · Cited by 1,035 · see citing works
Isaacs, J. S., Jung, Y. J., Mole, D. R., Lee, S., Torres-Cabala, C., Chung, Y.-L., Merino, M., Trepel, J., Zbar, B., Toro, J., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.06.017 · Cited by 958 · see citing works
MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system
Mellén, M., Ayata, P., Dewell, S., Kriaucionis, S., & Heintz, N. (2012) · Cell · doi:10.1016/j.cell.2012.11.022 · Cited by 943 · see citing works
Folic Acid for the Prevention of Colorectal Adenomas: A Randomized Clinical Trial
Cole, B. F., Baron, J. A., Sandler, R. S., Haile, R. W., Ahnen, D. J., Bresalier, R. S., McKeown-Eyssen, G., Summers, R. W., Rothstein, R. I., Burke, C. A., et al. (2007) · JAMA · doi:10.1001/jama.297.21.2351 · Cited by 929 · see citing works
Histone methylation in transcriptional control
Kouzarides, T. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00287-3 · Cited by 908 · see citing works
Logic of the Yeast Metabolic Cycle: Temporal Compartmentalization of Cellular Processes
Tu, B. P., Kudlicki, A. S., Rowicka, M., & McKnight, S. L. (2005) · Science · doi:10.1126/science.1120499 · Cited by 889 · see citing works
Self-citationPollard, P. J., Brière, J. J., Alam, N. A., Barwell, J., Barclay, E., Wortham, N. C., Hunt, T., Mitchell, M., Olpin, S., Moat, S. J., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi227 · Cited by 865 · see citing works
The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation
Wang, J., Hevi, S., Kurash, J. K., Lei, H., Gay, F., Bajko, J., Su, H., Sun, W., Chang, H., Xu, G., et al. (2008) · Nature Genetics · doi:10.1038/ng.268 · Cited by 827 · see citing works
Sinclair, K. D., Allegrucci, C., Singh, R., Gardner, D. S., Sebastian, S., Bispham, J., Thurston, A., Huntley, J. F., Rees, W. D., Maloney, C. A., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707258104 · Cited by 812 · see citing works
Cortellino, S., Xu, J., Sannai, M., Moore, R., Caretti, E., Cigliano, A., Le Coz, M., Devarajan, K., Wessels, A., Soprano, D., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.020 · Cited by 809 · see citing works
Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor
Hirsilä, M., Koivunen, P., Günzler, V., Kivirikko, K. I., & Myllyharju, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304982200 · Cited by 794 · see citing works
Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases
Hallows, W. C., Lee, S., & Denu, J. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604392103 · Cited by 792 · see citing works
Kim, H.-S., Patel, K., Muldoon-Jacobs, K., Bisht, K. S., Aykin-Burns, N., Pennington, J. D., van der Meer, R., Nguyen, P., Savage, J., Owens, K. M., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.11.023 · Cited by 785 · see citing works
Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer
van Haaften, G., Dalgliesh, G. L., Davies, H., Chen, L., Bignell, G., Greenman, C., Edkins, S., Hardy, C., O'Meara, S., Teague, J., et al. (2009) · Nature Genetics · doi:10.1038/ng.349 · Cited by 784 · see citing works
Sauve, A. A., Wolberger, C., Schramm, V. L., & Boeke, J. D. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133500 · Cited by 763 · see citing works
Systematic Identification of Pathways That Couple Cell Growth and Division in Yeast
Jorgensen, P., Nishikawa, J. L., Breitkreutz, B., & Tyers, M. (2002) · Science · doi:10.1126/science.1070850 · Cited by 753 · see citing works
Gross, S., Cairns, R. A., Minden, M. D., Driggers, E. M., Bittinger, M. A., Jang, H. G., Sasaki, M., Jin, S., Schenkein, D. P., Su, S. M., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092506 · Cited by 736 · see citing works
Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation
Koivunen, P., Lee, S., Duncan, C. G., Lopez, G., Lu, G., Ramkissoon, S., Losman, J. A., Joensuu, P., Bergmann, U., Gross, S., et al. (2012) · Nature · doi:10.1038/nature10898 · Cited by 727 · see citing works
Self-citationGenetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies
Abdel-Wahab, O., Mullally, A., Hedvat, C., Garcia-Manero, G., Patel, J., Wadleigh, M., Malinge, S., Yao, J., Kilpivaara, O., Bhat, R., et al. (2009) · Blood · doi:10.1182/blood-2009-03-210039 · Cited by 727 · see citing works
Schwer, B., Bunkenborg, J., Verdin, R. O., Andersen, J. S., & Verdin, E. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603968103 · Cited by 705 · see citing works
Losman, J.-A., Looper, R. E., Koivunen, P., Lee, S., Schneider, R. K., McMahon, C., Cowley, G. S., Root, D. E., Ebert, B. L., & Kaelin, W. G. (2013) · Science · doi:10.1126/science.1231677 · Cited by 703 · see citing works
Self-citationCai, L., Sutter, B. M., Li, B., & Tu, B. P. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.05.004 · Cited by 701 · see citing works
Metabolic Regulation of Epigenetics
Lu, C., & Thompson, C. B. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.06.001 · Cited by 699 · see citing works
The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins
McMahon, S. B., Van Buskirk, H. A., Dugan, K. A., Copeland, T. D., & Cole, M. D. (1998) · Cell · doi:10.1016/s0092-8674(00)81479-8 · Cited by 693 · see citing works
Nuclear ADP-Ribosylation Reactions in Mammalian Cells: Where Are We Today and Where Are We Going?
Hassa, P. O., Haenni, S. S., Elser, M., & Hottiger, M. O. (2006) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00040-05 · Cited by 682 · see citing works
Li, Z., Cai, X., Cai, C.-L., Wang, J., Zhang, W., Petersen, B. E., Yang, F.-C., & Xu, M. (2011) · Blood · doi:10.1182/blood-2010-12-325241 · Cited by 671 · see citing works
Sirtuin regulation of mitochondria: energy production, apoptosis, and signaling
Verdin, E., Hirschey, M. D., Finley, L. W. S., & Haigis, M. C. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.07.003 · Cited by 661 · see citing works
The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism
Sebastián, C., Zwaans, B. M. M., Silberman, D. M., Gymrek, M., Goren, A., Zhong, L., Ram, O., Truelove, J., Guimaraes, A. R., Toiber, D., et al. (2012) · Cell · doi:10.1016/j.cell.2012.10.047 · Cited by 660 · see citing works
Influence of Threonine Metabolism on <i>S</i> -Adenosylmethionine and Histone Methylation
Shyh-Chang, N., Locasale, J. W., Lyssiotis, C. A., Zheng, Y., Teo, R. Y., Ratanasirintrawoot, S., Zhang, J., Onder, T., Unternaehrer, J. J., Zhu, H., et al. (2013) · Science · doi:10.1126/science.1226603 · Cited by 638 · see citing works
Adam, J., Hatipoglu, E., O'Flaherty, L., Ternette, N., Sahgal, N., Lockstone, H., Baban, D., Nye, E., Stamp, G. W., Wolhuter, K., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.09.006 · Cited by 585 · see citing works
Sir2-dependent activation of acetyl-CoA synthetase by deacetylation of active lysine
Starai, V. J., Celic, I., Cole, R. N., Boeke, J. D., & Escalante-Semerena, J. C. (2002) · Science · doi:10.1126/science.1077650 · Cited by 564 · see citing works
The redox state of free nicotinamide-adenine dinucleotide phosphate in the cytoplasm of rat liver
Veech, R. L., Eggleston, L. V., & Krebs, H. A. (1969) · Biochemical Journal · doi:10.1042/bj1150609a · Cited by 563 · see citing works
Pansuriya, T. C., van Eijk, R., d'Adamo, P., van Ruler, M. A. J. H., Kuijjer, M. L., Oosting, J., Cleton-Jansen, A.-M., van Oosterwijk, J. G., Verbeke, S. L. J., Meijer, D., et al. (2011) · Nature Genetics · doi:10.1038/ng.1004 · Cited by 559 · see citing works
DNA Oxidation as Triggered by H3K9me2 Demethylation Drives Estrogen-Induced Gene Expression
Perillo, B., Ombra, M. N., Bertoni, A., Cuozzo, C., Sacchetti, S., Sasso, A., Chiariotti, L., Malorni, A., Abbondanza, C., & Avvedimento, E. V. (2008) · Science · doi:10.1126/science.1147674 · Cited by 529 · see citing works
KDM1B is a histone H3K4 demethylase required to establish maternal genomic imprints
Ciccone, D. N., Su, H., Hevi, S., Gay, F., Lei, H., Bajko, J., Xu, G., Li, E., & Chen, T. (2009) · Nature · doi:10.1038/nature08315 · Cited by 514 · see citing works
Guarente, L. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1100831 · Cited by 510 · see citing works
The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc
McMahon, S. B., Wood, M. A., & Cole, M. D. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.2.556-562.2000 · Cited by 494 · see citing works
Maternal methyl supplements increase offspring DNA methylation at <i>Axin fused</i>
Waterland, R. A., Dolinoy, D. C., Lin, J., Smith, C. A., Shi, X., & Tahiliani, K. G. (2006) · genesis · doi:10.1002/dvg.20230 · Cited by 480 · see citing works
Lerin, C., Rodgers, J. T., Kalume, D. E., Kim, S.-H., Pandey, A., & Puigserver, P. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.04.013 · Cited by 443 · see citing works
A HIF1α Regulatory Loop Links Hypoxia and Mitochondrial Signals in Pheochromocytomas
Dahia, P. L. M., Ross, K. N., Wright, M. E., Hayashida, C. Y., Santagata, S., Barontini, M., Kung, A. L., Sanso, G., Powers, J. F., Tischler, A. S., et al. (2005) · PLoS Genetics · doi:10.1371/journal.pgen.0010008 · Cited by 443 · see citing works
Takahashi, H., McCaffery, J. M., Irizarry, R. A., & Boeke, J. D. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.05.040 · Cited by 438 · see citing works
Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2
Amary, M. F., Damato, S., Halai, D., Eskandarpour, M., Berisha, F., Bonar, F., McCarthy, S., Fantin, V. R., Straley, K. S., Lobo, S., et al. (2011) · Nature Genetics · doi:10.1038/ng.994 · Cited by 428 · see citing works
Xia, X., Lemieux, M. E., Li, W., Carroll, J. S., Brown, M., Liu, X. S., & Kung, A. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810067106 · Cited by 410 · see citing works
Dependence of Mouse Embryonic Stem Cells on Threonine Catabolism
Wang, J., Alexander, P. B., Wu, L. C., Hammer, R. E., Cleaver, O. B., & McKnight, S. L. (2009) · Science · doi:10.1126/science.1173288 · Cited by 365 · see citing works
Self-citationMeCP2 binds to 5hmc enriched within active genes and accessible chromatin in the nervous system
Mellén, M., Ayata, P., Dewell, S. B., Kriaučionis, S., & Heintz, N. (2013) · Epigenetics & Chromatin · doi:10.1186/1756-8935-6-s1-p52 · Cited by 345 · see citing works
Will mandatory folic acid fortification prevent or promote cancer?
Kim, Y.-I. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.5.1123 · Cited by 332 · see citing works
The Sir2 family of protein deacetylases
Denu, J. M. (2005) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2005.08.010 · Cited by 325 · see citing works
A genomewide oscillation in transcription gates DNA replication and cell cycle
Klevecz, R. R., Bolen, J., Forrest, G., & Murray, D. B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306490101 · Cited by 321 · see citing works
Loenarz, C., & Schofield, C. J. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.07.002 · Cited by 274 · see citing works
Histone Methyl Transferases and Demethylases; Can They Link Metabolism and Transcription?
Teperino, R., Schoonjans, K., & Auwerx, J. H. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.09.004 · Cited by 270 · see citing works
Cyclic changes in metabolic state during the life of a yeast cell
Tu, B. P., Mohler, R. E., Liu, J. C., Dombek, K. M., Young, E. T., Synovec, R. E., & McKnight, S. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708365104 · Cited by 260 · see citing works
Self-citationHypoxia induces a novel signature of chromatin modifications and global repression of transcription
Johnson, A. B., Denko, N., & Barton, M. C. (2008) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2008.01.001 · Cited by 250 · see citing works
Sirtuin catalysis and regulation
Feldman, J. L., Dittenhafer-Reed, K. E., & Denu, J. M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r112.378877 · Cited by 248 · see citing works
The Heme-Bach1 Pathway in the Regulation of Oxidative Stress Response and Erythroid Differentiation
Igarashi, K., & Sun, J. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.107 · Cited by 243 · see citing works
Mechanisms involved in the regulation of histone lysine demethylases
Lan, F., Nottke, A. C., & Shi, Y. (2008) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.03.004 · Cited by 241 · see citing works
Epigenetic phenomena linked to diabetic complications
Pirola, L., Balcerczyk, A., Okabe, J., & El-Osta, A. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.188 · Cited by 239 · see citing works
Metabolic cycles as an underlying basis of biological oscillations.
Tu, B. P., & McKnight, S. L. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1980 · Cited by 229 · see citing works
Self-citationFAD-dependent lysine-specific demethylase-1 regulates cellular energy expenditure
Hino, S., Sakamoto, A., Nagaoka, K., Anan, K., Wang, Y., Mimasu, S., Umehara, T., Yokoyama, S., Kosai, K.-I., & Nakao, M. (2012) · Nature Communications · doi:10.1038/ncomms1755 · Cited by 226 · see citing works
Zhang, J., Ohta, T., Maruyama, A., Hosoya, T., Nishikawa, K., Maher, J. M., Shibahara, S., Itoh, K., & Yamamoto, M. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00700-06 · Cited by 213 · see citing works
Sirtuins, Aging, and MetabolismPreprint
Guarente, L. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.010629 · Cited by 204 · see citing works
Stefanska, B., Karlic, H., Varga, F., Fabianowska‐Majewska, K., & Haslberger, A. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02002.x · Cited by 200 · cited 1× · see citing works
“Examples include various B vitamins, retinoic acid, vitamin D3, reservatrol, genistein and daidzein, epigallocatechin-3-gallate (EGCG), and curcumin (Gerhauser, 2013; Stefanska et al., 2012).”
Effect of Combined Folic Acid, Vitamin B 6 , and Vitamin B 12 on Cancer Risk in Women
Zhang, S. M., Cook, N. R., Albert, C. M., Gaziano, J. M., Buring, J. E., & Manson, J. E. (2008) · JAMA · doi:10.1001/jama.2008.555 · Cited by 195 · see citing works
Cancer Chemoprevention and Nutri-Epigenetics: State of the Art and Future Challenges
Gerhauser, C. (2012) · Topics in Current Chemistry · doi:10.1007/128_2012_360 · Cited by 194 · see citing works
Muto, A., Hoshino, H., Madisen, L., Yanai, N., Obinata, M., Karasuyama, H., Hayashi, N., Nakauchi, H., Yamamoto, M., Groudine, M., et al. (1998) · The EMBO Journal · doi:10.1093/emboj/17.19.5734 · Cited by 190 · see citing works
Methionine adenosyltransferase II serves as a transcriptional corepressor of Maf oncoprotein
Katoh, Y., Ikura, T., Hoshikawa, Y., Tashiro, S., Ito, T., Ohta, M., Kera, Y., Noda, T., & Igarashi, K. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.02.018 · Cited by 185 · see citing works
SIRT3 regulates mitochondrial protein acetylation and intermediary metabolism
Hirschey, M. D., Shimazu, T., Huang, J. Y., Schwer, B., & Verdin, E. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.010850 · Cited by 180 · see citing works
Metabolomics-driven quantitative analysis of ammonia assimilation in E. coli
Yuan, J., Doucette, C. D., Fowler, W. U., Feng, X., Piazza, M., Rabitz, H. A., Wingreen, N. S., & Rabinowitz, J. D. (2009) · Molecular Systems Biology · doi:10.1038/msb.2009.60 · Cited by 178 · see citing works
Pollard, P. J., Spencer‐Dene, B., Shukla, D., Howarth, K. M., Nye, E. L., El-Bahrawy, M. A., Deheragoda, M. G., Kolatsi‐Joannou, M., McDonald, S. A. C., Martin, A., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.02.005 · Cited by 177 · see citing works
Succinate inhibition of α-ketoglutarate-dependent enzymes in a yeast model of paraganglioma
Smith, E. H., Janknecht, R., & Maher, L. J. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm275 · Cited by 169 · see citing works
Dominguez-Salas, P., Cox, S. E., Prentice, A. M., Hennig, B. J., & Moore, S. E. (2012) · Proceedings of the Nutrition Society · doi:10.1017/s0029665111003338 · Cited by 163 · see citing works
Ji, H., Wu, G. Y., Zhan, X., Nolan, A., Koh, C. M., Marzo, A. D., Doan, H. M., Fan, J., Cheadle, C., Fallahi, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026057 · Cited by 162 · see citing works
Plasmacytic Transcription Factor Blimp-1 Is Repressed by Bach2 in B Cells
Ochiai, K., Katoh, Y., Ikura, T., Hoshikawa, Y., Noda, T., Karasuyama, H., Tashiro, S., Muto, A., & Igarashi, K. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607592200 · Cited by 162 · see citing works
The control of histone methylation and gene expression by oxidative stress, hypoxia, and metals
Chervona, Y., & Costa, M. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.07.020 · Cited by 161 · see citing works
Inhibition of succinate dehydrogenase dysregulates histone modification in mammalian cells
Cervera, A. M., Bayley, J.-P., Devilee, P., & McCreath, K. J. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-89 · Cited by 156 · see citing works
Dynamics of histone acetylation in vivo. A function for acetylation turnover?
Waterborg, J. H. (2002) · Biochemistry and Cell Biology · doi:10.1139/o02-080 · Cited by 155 · see citing works
Driving the cell cycle through metabolism
Cai, L., & Tu, B. P. (2012) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-092910-154010 · Cited by 140 · see citing works
Hypoxia induces trimethylated H3 lysine 4 by inhibition of JARID1A demethylase
Zhou, X., Sun, H., Chen, H., Zavadil, J., Kluz, T., Arita, A., & Costa, M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2942 · Cited by 134 · see citing works
Tausendschön, M., Dehne, N., & Brüne, B. (2011) · Cytokine · doi:10.1016/j.cyto.2010.11.002 · Cited by 132 · see citing works
Effects ofTET2mutations on DNA methylation in chronic myelomonocytic leukemia
Yamazaki, J., Taby, R. F., Vasanthakumar, A., Macrae, T. A., Ostler, K. R., Shen, L., Kantarjian, H. M., Estecio, M. R., Jelı́nek, J., Godley, L. A., et al. (2012) · Epigenetics · doi:10.4161/epi.7.2.19015 · Cited by 122 · see citing works
Hintze, K. J., Katoh, Y., Igarashi, K., & Theil, E. C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700254200 · Cited by 110 · see citing works
Polymorphisms in 1-carbon metabolism, epigenetics and folate-related pathologies
Stover, P. J. (2011) · Lifestyle Genomics · doi:10.1159/000334586 · Cited by 109 · see citing works
NAD+ as a Signaling Molecule Modulating MetabolismPreprint
Cantó, C., & Auwerx, J. H. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2012.76.010439 · Cited by 109 · see citing works
A COMMON FACTOR IN THE ENZYMATIC ACETYLATION OF SULFANILAMIDE AND OF CHOLINE
Lipmann, F. A., & Kaplan, N. O. (1946) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41419-0 · Cited by 108 · see citing works
Bjorkman, D. (2000) · Journal watch · doi:10.1056/jg200008010000003 · Cited by 96 · see citing works
The human L-threonine 3-dehydrogenase gene is an expressed pseudogene
Edgar, A. J. (2002) · BMC Genetics · doi:10.1186/1471-2156-3-18 · Cited by 92 · see citing works
On Acetyl-CoA as a Gauge of Cellular Metabolic StatePreprint
Cai, L., & Tu, B. P. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.010769 · Cited by 84 · see citing works
Evans, C., Bogan, K. L., Song, P., Burant, C. F., Kennedy, R. T., & Brenner, C. (2010) · BMC Chemical Biology · doi:10.1186/1472-6769-10-2 · Cited by 81 · see citing works
High-resolution timing of cell cycle-regulated gene expression
Rowicka, M., Kudlicki, A. S., Tu, B. P., & Otwinowski, Z. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706022104 · Cited by 79 · see citing works
Intracellular alpha-ketoglutarate controls the efficacy of renal organic anion transport
Pritchard, J. B. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10636-8 · Cited by 78 · see citing works
Cloning and expression of murine S-adenosylmethionine synthetase
Sakata, S. F., Shelly, L. L., Ruppert, S., Schutz, G., & Chou, J. Y. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85198-0 · Cited by 75 · see citing works
SDH5 mutations and familial paraganglioma: somewhere Warburg is smiling
Kaelin, W. G. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.08.013 · Cited by 67 · see citing works
Self-citationMutation in<i>TET2</i>in Myeloid Cancers
(2009) · New England Journal of Medicine · doi:10.1056/nejmc091348 · Cited by 66 · see citing works
Targeted killing of a mammalian cell based upon its specialized metabolic state
Alexander, P. B., Wang, J., & McKnight, S. L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111312108 · Cited by 64 · see citing works
Self-citationHardie, D. G. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.010819 · Cited by 54 · see citing works
Modulating acetyl-CoA binding in the GCN5 family of histone acetyltransferases
Langer, M. R., Fry, C. J., Peterson, C. L., & Denu, J. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203251200 · Cited by 45 · see citing works
Neuregulin 1-HER axis as a key mediator of hyperglycemic memory effects in breast cancer
Park, J., Sarode, V. R., Euhus, D., Kittler, R., & Scherer, P. E. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1214400109 · Cited by 44 · see citing works
Andreeva (2012) · doi:10.1001/archinternmed.2011.1450 · Cited by 40 · see citing works
Effect of Combined Folic Acid, Vitamin B6, and Vitamin B12 on Colorectal Adenoma
Song, Y., Manson, J. E., Lee, I.-M., Cook, N. R., Paul, L., Selhub, J., Giovannucci, E., & Zhang, S. M. (2012) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djs370 · Cited by 38 · see citing works
Metabolic specialization of mouse embryonic stem cells
Wang, J., Alexander, P., & McKnight, S. L. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.010835 · Cited by 35 · see citing works
Self-citationEvidence of carbon monoxide-mediated phase advancement of the yeast metabolic cycle
Tu, B. P., & McKnight, S. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907786106 · Cited by 24 · see citing works
Self-citation
Flagged first, then by citations
1 of the 136 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Metabolic regulation of gene expression by histone lactylation
Zhang, D., Tang, Z., Huang, H., Zhou, G., Cui, C., Weng, Y., Liu, W., Kim, S., Lee, S., Perez-Neut, M., et al. (2019) · Nature · doi:10.1038/s41586-019-1678-1 · Cited by 4,371 · see citing works
Fundamentals of Cancer Metabolism
DeBerardinis, R. J., & Chandel, N. S. (2016) · Science Advances · doi:10.1126/sciadv.1600200 · Cited by 3,013 · see citing works
Understanding the Intersections between Metabolism and Cancer Biology
Heiden, M. G. V., & DeBerardinis, R. J. (2017) · Cell · doi:10.1016/j.cell.2016.12.039 · Cited by 2,316 · see citing works
Serine, glycine and one-carbon units: cancer metabolism in full circle
Locasale, J. W. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3557 · Cited by 1,669 · see citing works
Cantó, C., Menzies, K. J., & Auwerx, J. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.05.023 · Cited by 1,648 · see citing works
Cancer metabolism: a therapeutic perspective
Martinez-Outschoorn, U. E., Peiris-Pagés, M., Pestell, R. G., Sotgia, F., & Lisanti, M. P. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.60 · Cited by 1,505 · see citing works
Targeting mitochondria metabolism for cancer therapy
Weinberg, S. E., & Chandel, N. S. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1712 · Cited by 1,385 · see citing works
NAD <sup>+</sup> in aging, metabolism, and neurodegeneration
Verdin, E. (2015) · Science · doi:10.1126/science.aac4854 · Cited by 1,319 · see citing works
T cell metabolism drives immunity
Buck, M. D., O’Sullivan, D., & Pearce, E. L. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20151159 · Cited by 1,190 · see citing works
Mitochondria are the powerhouses of immunity
Mills, E. L., Kelly, B., & O'Neill, L. A. J. (2017) · Nature Immunology · doi:10.1038/ni.3704 · Cited by 1,161 · see citing works
Reversing DNA Methylation: Mechanisms, Genomics, and Biological Functions
Wu, H., & Zhang, Y. (2014) · Cell · doi:10.1016/j.cell.2013.12.019 · Cited by 1,065 · see citing works
Signal Transduction in CancerPreprint
Sever, R., & Brugge, J. S. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006098 · Cited by 992 · see citing works
Mitochondria in the Regulation of Innate and Adaptive Immunity
Weinberg, S. E., Sena, L. A., & Chandel, N. S. (2015) · Immunity · doi:10.1016/j.immuni.2015.02.002 · Cited by 960 · see citing works
Acetyl-CoA and the regulation of metabolism: mechanisms and consequences
Shi, L., & Tu, B. P. (2015) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2015.02.003 · Cited by 903 · see citing works
Cellular senescence and its effector programs
Salama, R., Sadaie, M., Hoare, M., & Narita, M. (2014) · Genes & Development · doi:10.1101/gad.235184.113 · Cited by 855 · see citing works
Mitochondria as a therapeutic target for common pathologies
Murphy, M. P., & Hartley, R. C. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.174 · Cited by 832 · see citing works
The world of protein acetylation
Drazic, A., Myklebust, L. M., Ree, R., & Arnesen, T. (2016) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2016.06.007 · Cited by 798 · see citing works
An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma
Hakimi, A. A., Reznik, E., Lee, C., Creighton, C. J., Brannon, A. R., Luna, A., Aksoy, B. A., Liu, E. M., Shen, R., Lee, W., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2015.12.004 · Cited by 791 · see citing works
Metabolic reprogramming and epigenetic modifications on the path to cancer
Sun, L., Zhang, H., & Gao, P. (2021) · Protein & Cell · doi:10.1007/s13238-021-00846-7 · Cited by 796 · see citing works
Metabolic Regulation of Gene Expression by Histone Lysine β-Hydroxybutyrylation
Xie, Z., Zhang, D., Chung, D., Tang, Z., Huang, H., Dai, L., Qi, S., Li, J., Colak, G., Chen, Y., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.03.036 · Cited by 744 · see citing works
Obesity Pathogenesis: An Endocrine Society Scientific Statement
Schwartz, M. W., Seeley, R. J., Zeltser, L. M., Drewnowski, A., Ravussin, E., Redman, L. M., & Leibel, R. L. (2017) · Endocrine Reviews · doi:10.1210/er.2017-00111 · Cited by 727 · see citing works
Interpreting the language of histone and DNA modifications
Rothbart, S. B., & Strahl, B. D. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.03.001 · Cited by 721 · see citing works
Immunometabolic Pathways in BCG-Induced Trained Immunity
Arts, R. J. W., Carvalho, A., Rocca, C. L., Palma, C., Rodrigues, F. J. S., Silvestre, R., Kleinnijenhuis, J., Lachmandas, E., Gonçalves, L. G., Belinha, A., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.11.011 · Cited by 677 · see citing works
Comerford, S. A., Huang, Z., Du, X., Wang, Y., Cai, L., Witkiewicz, A. K., Walters, H., Tantawy, M. N., Fu, A., Manning, H. C., et al. (2014) · Cell · doi:10.1016/j.cell.2014.11.020 · Cited by 681 · see citing works
Self-citationMitochondria and Mitochondrial ROS in Cancer: Novel Targets for Anticancer Therapy
Yang, Y., Karakhanova, S., Hartwig, W., D’Haese, J. G., Philippov, P. P., Werner, J., & Bazhin, A. V. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25349 · Cited by 671 · see citing works
Intracellular Crotonyl-CoA Stimulates Transcription through p300-Catalyzed Histone Crotonylation
Sabari, B. R., Tang, Z., Huang, H., Yong-Gonzalez, V., Molina, H., Kong, H. E., Dai, L., Shimada, M., Cross, J. R., Zhao, Y., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.02.029 · Cited by 659 · see citing works
Mechanisms and Implications of Metabolic Heterogeneity in Cancer
Kim, J., & DeBerardinis, R. J. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.08.013 · Cited by 606 · see citing works
Mitochondria as signaling organelles
Chandel, N. S. (2014) · BMC Biology · doi:10.1186/1741-7007-12-34 · Cited by 576 · see citing works
Stem cell metabolism in tissue development and aging
Shyh‐Chang, N., Daley, G. Q., & Cantley, L. C. (2013) · Development · doi:10.1242/dev.091777 · Cited by 573 · see citing works
Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation
Lee, J. V., Carrer, A., Shah, S., Snyder, N. W., Wei, S., Venneti, S., Worth, A. J., Yuan, Z.-F., Lim, H.-W., Liu, S., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.06.004 · Cited by 563 · see citing works
Dendritic cell migration in inflammation and immunity
Liu, J., Zhang, X., Cheng, Y., & Cao, X. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00726-4 · Cited by 543 · see citing works
Altered metabolism in cancer: insights into energy pathways and therapeutic targets
Tufail, M., Jiang, C.-H., & Li, N. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02119-3 · Cited by 534 · see citing works
Interplay between Metabolism and Epigenetics: A Nuclear Adaptation to Environmental Changes
Etchegaray, J., & Mostoslavsky, R. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.05.029 · Cited by 521 · see citing works
The impact of cellular metabolism on chromatin dynamics and epigenetics
Reid, M. A., Dai, Z., & Locasale, J. W. (2017) · Nature Cell Biology · doi:10.1038/ncb3629 · Cited by 515 · see citing works
Acetyl-CoA synthetase regulates histone acetylation and hippocampal memory
Mews, P., Donahue, G., Drake, A. M., Luczak, V., Abel, T., & Berger, S. L. (2017) · Nature · doi:10.1038/nature22405 · Cited by 514 · see citing works
TCA Cycle and Mitochondrial Membrane Potential Are Necessary for Diverse Biological Functions
Martínez‐Reyes, I., Diebold, L. P., Kong, H., Schieber, M., Huang, H., Hensley, C. T., Mehta, M., Wang, T., Santos, J. H., Woychik, R. P., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.12.002 · Cited by 512 · see citing works
Mitochondrial Dysfunction in Cancer
Boland, M. L., Chourasia, A. H., & Macleod, K. F. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00292 · Cited by 502 · see citing works
The evolving metabolic landscape of chromatin biology and epigenetics
Dai, Z., Ramesh, V., & Locasale, J. W. (2020) · Nature Reviews Genetics · doi:10.1038/s41576-020-0270-8 · Cited by 494 · see citing works
Emerging Roles for Branched-Chain Amino Acid Metabolism in Cancer
Sivanand, S., & Heiden, M. G. V. (2020) · Cancer Cell · doi:10.1016/j.ccell.2019.12.011 · Cited by 488 · see citing works
McDonald, O. G., Li, X., Saunders, T., Tryggvadottir, R., Mentch, S. J., Warmoes, M. O., Word, A. E., Carrer, A., Salz, T. H., Natsume, S., et al. (2017) · Nature Genetics · doi:10.1038/ng.3753 · Cited by 494 · see citing works
Inside and out: the activities of senescence in cancer
Pérez-Mancera, P. A., Young, A. R. J., & Narita, M. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3773 · Cited by 462 · see citing works
Lysine 2-hydroxyisobutyrylation is a widely distributed active histone mark
Dai, L., Peng, C., Montellier, E., Lu, Z., Chen, Y., Ishii, H., Debernardi, A., Buchou, T., Rousseaux, S., Jin, F., et al. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1497 · Cited by 460 · see citing works
Akt-mTORC1 signaling regulates Acly to integrate metabolic input to control of macrophage activation
Covarrubias, A. J., Aksoylar, H., Yu, J., Snyder, N. W., Worth, A. J., Iyer, S. S., Wang, J., Ben‐Sahra, I., Byles, V., Polynne-Stapornkul, T., et al. (2016) · eLife · doi:10.7554/elife.11612 · Cited by 455 · see citing works
The nexus of chromatin regulation and intermediary metabolism
Gut, P., & Verdin, E. M. (2013) · Nature · doi:10.1038/nature12752 · Cited by 419 · see citing works
Mitochondrial calcium exchange in physiology and disease
Garbincius, J. F., & Elrod, J. W. (2021) · Physiological Reviews · doi:10.1152/physrev.00041.2020 · Cited by 413 · see citing works
Methionine is a metabolic dependency of tumor-initiating cells
Wang, Z., Yip, L. Y., Lee, J. H. J., Wu, Z., Chew, H. Y., Chong, P. K. W., Teo, C. C., Ang, H. Y.-K., Peh, K. L. E., Yuan, J. X., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0423-5 · Cited by 425 · see citing works
Mitochondria as central regulators of neural stem cell fate and cognitive function
Khacho, M., Harris, R., & Slack, R. S. (2018) · Nature reviews. Neuroscience · doi:10.1038/s41583-018-0091-3 · Cited by 396 · see citing works
Metabolic control of TH17 and induced Treg cell balance by an epigenetic mechanism
Xu, T., Stewart, K. M., Wang, X., Liu, K., Xie, M., Ryu, J. K., Li, K., Ma, T., Wang, H., Ni, L., et al. (2017) · Nature · doi:10.1038/nature23475 · Cited by 395 · see citing works
Extracellular Metabolic Energetics Can Promote Cancer Progression
Loo, J. M., Scherl, A., Nguyen, A., Man, F. Y., Weinberg, E., Zeng, Z., Saltz, L., Paty, P. B., & Tavazoie, S. F. (2015) · Cell · doi:10.1016/j.cell.2014.12.018 · Cited by 393 · see citing works
Epigenetic Regulation in Neurodegenerative Diseases
Berson, A., Nativio, R., Berger, S. L., & Bonini, N. M. (2018) · Trends in Neurosciences · doi:10.1016/j.tins.2018.05.005 · Cited by 386 · see citing works
Sex differences in cancer mechanisms
Rubin, J. B., Lagas, J. S., Broestl, L., Sponagel, J., Rockwell, N., Rhee, G., Rosen, S. F., Chen, S., Klein, R. S., Imoukhuede, P. I., et al. (2020) · Biology of Sex Differences · doi:10.1186/s13293-020-00291-x · Cited by 369 · see citing works
Menko, F. H., Maher, E. R., Schmidt, L. S., Middelton, L. A., Aittomäki, K., Tomlinson, I. P. M., Richard, S., & Linehan, W. M. (2014) · Familial Cancer · doi:10.1007/s10689-014-9735-2 · Cited by 357 · see citing works
The Link Between Angiogenesis and Endothelial Metabolism
Potente, M., & Carmeliet, P. (2016) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021115-105134 · Cited by 353 · see citing works
BCAT1 restricts αKG levels in AML stem cells leading to IDHmut-like DNA hypermethylation
Raffel, S., Falcone, M., Kneisel, N., Hansson, J., Wang, W., Lutz, C., Bullinger, L., Poschet, G., Nonnenmacher, Y., Barnert, A., et al. (2017) · Nature · doi:10.1038/nature24294 · Cited by 354 · see citing works
Histone Acetylation Enzymes Coordinate Metabolism and Gene Expression
Shen, Y., Wei, W., & Zhou, D. (2015) · Trends in Plant Science · doi:10.1016/j.tplants.2015.07.005 · Cited by 355 · see citing works
Lipids Reprogram Metabolism to Become a Major Carbon Source for Histone Acetylation
McDonnell, E., Crown, S. B., Fox, D. B., Kitir, B., Ilkayeva, O., Olsen, C. A., Grimsrud, P. A., & Hirschey, M. D. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.10.012 · Cited by 343 · see citing works
Mitochondrial Dynamics at the Interface of Immune Cell Metabolism and Function
Rambold, A. S., & Pearce, E. L. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.08.006 · Cited by 341 · see citing works
Mullen, A. R., Hu, Z., Shi, X., Jiang, L., Boroughs, L. K., Kovacs, Z., Boriack, R., Rakheja, D., Sullivan, L. B., Linehan, W. M., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.04.037 · Cited by 337 · see citing works
Protein acetylation in metabolism – metabolites and cofactors
Menzies, K. J., Zhang, H., Katsyuba, E., & Auwerx, J. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.181 · Cited by 331 · see citing works
Metabolomics for Plant Improvement: Status and Prospects
Kumar, R., Bohra, A., Pandey, A. K., Pandey, M. K., & Kumar, A. (2017) · Frontiers in Plant Science · doi:10.3389/fpls.2017.01302 · Cited by 330 · see citing works
Metabolic regulation of stem cell function in tissue homeostasis and organismal ageing
Chandel, N. S., Jasper, H., Ho, T. T., & Passegué, E. (2016) · Nature Cell Biology · doi:10.1038/ncb3385 · Cited by 326 · see citing works
Metabolic signatures of cancer cells and stem cells
Intlekofer, A. M., & Finley, L. W. S. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0032-0 · Cited by 322 · see citing works
Keating, S. T., & El‐Osta, A. (2015) · Circulation Research · doi:10.1161/circresaha.116.303936 · Cited by 315 · see citing works
Luo, T., Zhang, Y., Wang, C., Wang, X., Zhou, J., Shen, M., Zhao, Y., Fu, Z., & Jin, Y. (2019) · Environmental Pollution · doi:10.1016/j.envpol.2019.113122 · Cited by 321 · see citing works
Mitochondrial function — gatekeeper of intestinal epithelial cell homeostasis
Rath, E., Moschetta, A., & Haller, D. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0021-x · Cited by 306 · see citing works
Dysregulated metabolism contributes to oncogenesis
Hirschey, M. D., DeBerardinis, R. J., Diehl, A. M., Drew, J. E., Frezza, C., Green, M. F., Jones, L. W., Ko, Y. H., Le, A., Lea, M. A., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.10.002 · Cited by 306 · see citing works
Menachery, V. D., Eisfeld, A. J., Schäfer, A., Josset, L., Sims, A. M., Proll, S. C., Fan, S., Li, C., Neumann, G., Tilton, S. C., et al. (2014) · mBio · doi:10.1128/mbio.01174-14 · Cited by 307 · see citing works
NAD+ Metabolism Maintains Inducible PD-L1 Expression to Drive Tumor Immune Evasion
Lv, H., Lv, G., Chen, C., Zong, Q., Jiang, G., Ye, D., Cui, X., He, Y., Xiang, W., Han, Q. Y., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.10.021 · Cited by 301 · see citing works
α-Ketoglutarate links p53 to cell fate during tumour suppression
Morris, J. P., Yashinskie, J. J., Koche, R., Chandwani, R., Tian, S., Chen, C.-C., Baslan, T., Marinkovic, Z. S., Sánchez-Rivera, F. J., Leach, S. D., et al. (2019) · Nature · doi:10.1038/s41586-019-1577-5 · Cited by 296 · see citing works
Mitochondrial complex ii: At the crossroads
Bezawork-Geleta, A., Rohlena, J., Dong, L., Pacak, K., & Neuzil, J. (2017) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2017.01.003 · Cited by 295 · see citing works
Metabolic and Epigenetic Coordination of T Cell and Macrophage Immunity
Phan, A. T., Goldrath, A. W., & Glass, C. K. (2017) · Immunity · doi:10.1016/j.immuni.2017.04.016 · Cited by 291 · see citing works
The Ten-Eleven Translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases
Solary, É., Bernard, O., Tefferi, A., Fuks, F., & Vainchenker, W. (2013) · Leukemia · doi:10.1038/leu.2013.337 · Cited by 284 · see citing works
α-Ketoglutarate Accelerates the Initial Differentiation of Primed Human Pluripotent Stem Cells
TeSlaa, T., Chaikovsky, A. C., Lipchina, I., Escobar, S. L., Hochedlinger, K., Huang, J., Graeber, T. G., Braas, D., & Teitell, M. A. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.07.002 · Cited by 287 · see citing works
Grassian, A. R., Parker, S. J., Davidson, S. M., Divakaruni, A. S., Green, C. R., Zhang, X., Slocum, K. L., Pu, M., Lin, F., Vickers, C., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0772-t · Cited by 280 · see citing works
Metabolic Enzymes Moonlighting in the Nucleus: Metabolic Regulation of Gene Transcription
Boukouris, A. E., Zervopoulos, S. D., & Michelakis, E. D. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.05.013 · Cited by 274 · see citing works
Benton, M. C., Johnstone, A. C., Eccles, D., Harmon, B. T., Hayes, M. T., Lea, R. A., Griffiths, L. R., Hoffman, E. P., Stubbs, R. S., & Macartney-Coxson, D. P. (2015) · Genome biology · doi:10.1186/s13059-014-0569-x · Cited by 273 · see citing works
I’m Eating for Two: Parental Dietary Effects on Offspring Metabolism
Rando, O. J., & Simmons, R. A. (2015) · Cell · doi:10.1016/j.cell.2015.02.021 · Cited by 271 · see citing works
Bersten, D. C., Sullivan, A. E., Peet, D. J., & Whitelaw, M. L. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3621 · Cited by 267 · see citing works
Borgo, F., Riva, A., Benetti, A., Casiraghi, M. C., Bertelli, S., Garbossa, S., Anselmetti, S., Scarone, S., Pontiroli, A. E., Morace, G., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0179739 · Cited by 267 · see citing works
A blueprint for tumor-infiltrating B cells across human cancers
Ma, J., Wu, Y. C., Ma, L., Yang, X., Zhang, T., Song, G., Li, T., Gao, K., Shen, X., Lin, J., et al. (2024) · Science · doi:10.1126/science.adj4857 · Cited by 262 · see citing works
Eisenberg, T., Schroeder, S., Andryushkova, A., Pendl, T., Küttner, V., Bhukel, A., Mariño, G., Pietrocola, F., Harger, A., Zimmermann, A., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.02.010 · Cited by 256 · see citing works
Altered chromosomal topology drives oncogenic programs in SDH-deficient GISTs
Flavahan, W. A., Drier, Y., Johnstone, S. E., Hemming, M. L., Tarjan, D. R., Hegazi, E., Shareef, S. J., Javed, N. M., Raut, C. P., Eschle, B. K., et al. (2019) · Nature · doi:10.1038/s41586-019-1668-3 · Cited by 253 · see citing works
Li, L., & Li, W. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.01.004 · Cited by 254 · see citing works
Tarrade, A., Panchenko, P., Junien, C., & Gabory, A. (2015) · Journal of Experimental Biology · doi:10.1242/jeb.110320 · Cited by 251 · see citing works
Tricarboxylic Acid (TCA) Cycle Intermediates: Regulators of Immune Responses
Choi, I., Son, H., & Baek, J.-H. (2021) · Life · doi:10.3390/life11010069 · Cited by 244 · see citing works
Multifaceted role of branched-chain amino acid metabolism in cancer
Peng, H., Wang, Y., & Luo, W. (2020) · Oncogene · doi:10.1038/s41388-020-01480-z · Cited by 244 · see citing works
Metabolism in physiological cell proliferation and differentiation
Agathocleous, M., & Harris, W. A. (2013) · Trends in Cell Biology · doi:10.1016/j.tcb.2013.05.004 · Cited by 240 · see citing works
Metabolic regulation of chromatin modifications and gene expression
Schvartzman, J. M., Thompson, C. B., & Finley, L. W. S. (2018) · Journal of Cell Biology · doi:10.1083/jcb.201803061 · Cited by 233 · see citing works
NAD metabolic dependency in cancer is shaped by gene amplification and enhancer remodelling
Chowdhry, S., Zanca, C., Rajkumar, U., Koga, T., Diao, Y., Raviram, R., Liu, F., Turner, K. M., Yang, H., Brunk, E., et al. (2019) · Nature · doi:10.1038/s41586-019-1150-2 · Cited by 232 · see citing works
Nuclear ADP-Ribosylation and Its Role in Chromatin Plasticity, Cell Differentiation, and Epigenetics
Hottiger, M. O. (2015) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060614-034506 · Cited by 224 · see citing works
Characterization of histone acylations links chromatin modifications with metabolism
Simithy, J., Sidoli, S., Yuan, Z., Coradin, M., Bhanu, N. V., Marchione, D. M., Klein, B. J., Bazilevsky, G. A., McCullough, C. E., Magin, R. S., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01384-9 · Cited by 226 · see citing works
Causes of genome instability: the effect of low dose chemical exposures in modern society
Langie, S. A. S., Koppen, G., Desaulniers, D. M., Al‐Mulla, F., Al-Temaimi, R. A., Amedei, A., Azqueta, A., Bisson, W. H., Brown, D. G., Brunborg, G., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv031 · Cited by 229 · see citing works
Structural Basis for Regulation of METTL16, an S-Adenosylmethionine Homeostasis Factor
Doxtader, K. A., Wang, P., Scarborough, A. M., Seo, D., Conrad, N. K., & Nam, Y. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.07.025 · Cited by 226 · see citing works
Cancer Cells Don’t Live Alone: Metabolic Communication within Tumor Microenvironments
Li, F., & Simon, M. C. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.06.018 · Cited by 226 · see citing works
Saunier, E. F., Benelli, C., & Bortoli, S. (2015) · International Journal of Cancer · doi:10.1002/ijc.29564 · Cited by 217 · see citing works
Crossing epigenetic frontiers: the intersection of novel histone modifications and diseases
Yao, W., Hu, X., & Wang, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01918-w · Cited by 229 · see citing works
Pluripotent stem cell energy metabolism: an update
TeSlaa, T. A., & Teitell, M. A. (2014) · The EMBO Journal · doi:10.15252/embj.201490446 · Cited by 212 · see citing works
Undercover: gene control by metabolites and metabolic enzymesPreprint
van der Knaap, J. A., & Verrijzer, C. P. (2016) · Genes & Development · doi:10.1101/gad.289140.116 · Cited by 213 · see citing works
Energy Metabolism Regulates Stem Cell Pluripotency
Tsogtbaatar, E., Landin, C., Minter‐Dykhouse, K., & Folmes, C. D. L. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00087 · Cited by 208 · see citing works
Metabolic Alterations in Aging Macrophages: Ingredients for Inflammaging?
van Beek, A. A., Van den Bossche, J., Mastroberardino, P. G., de Winther, M. P. J., & Leenen, P. J. M. (2019) · Trends in Immunology · doi:10.1016/j.it.2018.12.007 · Cited by 207 · see citing works
- Authors
- Kaelin, W. G., & McKnight, S. L.
- Affiliations
- Brigham and Women's Hospital (US)
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Kaelin, William G.
- McKnight, Steven L.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2013-03
- Volume
- 153
- Issue
- 1
- Pages
- 56-69
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC3775362
- OpenAlex
- W2035010201
- Semantic Scholar
- 732b8265382027a841509c4b7ef3185231cba71c
- Cited by
- 920
- References
- 136
- Citations by year
- 2026: 89 · 2025: 41 · 2024: 52 · 2023: 49 · 2022: 57 · 2021: 85 · 2020: 74 · 2019: 84 · 2018: 58 · 2017: 70 · 2016: 73 · 2015: 82 · 2014: 71 · 2013: 32
- FWCI
- 8.09
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Howard Hughes Medical Institute
- National Cancer Institute (R01CA068490, R01CA076120)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- metabolism, epigenetics, histone methylation, histone acetylation, DNA methylation, epigenetic regulation, succinate dehydrogenase, fumarase, isocitrate dehydrogenase, cancer, nutrition and disease
- MeSH terms
- Acetylation, Animals, Disease, Histones, Humans, Metabolism, Methylation, DNA Methylation, Epigenesis, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-06.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-06.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review